albuterol has been researched along with Obstructive Lung Diseases in 402 studies
Albuterol: A short-acting beta-2 adrenergic agonist that is primarily used as a bronchodilator agent to treat ASTHMA. Albuterol is prepared as a racemic mixture of R(-) and S(+) stereoisomers. The stereospecific preparation of R(-) isomer of albuterol is referred to as levalbuterol.
albuterol : A member of the class of phenylethanolamines that is 4-(2-amino-1-hydroxyethyl)-2-(hydroxymethyl)phenol having a tert-butyl group attached to the nirogen atom. It acts as a beta-adrenergic agonist used in the treatment of asthma and chronic obstructive pulmonary disease (COPD).
| Excerpt | Relevance | Reference |
|---|---|---|
| "We compared the frequency and severity of cardiac arrhythmias during combined oral theophylline and inhaled salbutamol vs." | 9.06 | Theophylline and salbutamol in combination in patients with obstructive pulmonary disease and concurrent heart disease: effect on cardiac arrhythmias. ( Huikuri, H; Korhonen, UR; Linnaluoto, M; Poukkula, A, 1989) |
| "The purpose of this study was to observe the effectiveness of lidocaine in suppressing cough which is a logical extension of its established use in bronchoscopy." | 7.71 | Lidocaine inhalation for cough suppression. ( Udezue, E, 2001) |
| "The concentrations of theophylline, terbutaline and salbutamol in post-mortem blood samples from 68 patients (17-85 years old) with asthma or chronic obstructive lung disease, 54 of whom had died of asthma, were analysed." | 7.67 | Post-mortem concentrations of salbutamol, terbutaline and theophylline in asthma patients. ( Boman, G; Lindsjö, M; Lindström, B; Strandberg, K; Wiholm, BE, 1987) |
| "We describe the occurrence of sudden severe bronchospasm and respiratory arrest following dipyridamole infusion in a patient with chronic obstructive pulmonary disease predominantly of the emphysematous type." | 7.67 | Severe bronchospasm followed by respiratory arrest during thallium-dipyridamole imaging. ( Cerino, M; Laverdiere, M; Lette, J; Prenovault, J; Tremblay, J, 1989) |
| " Then after a further 3 wk of dosing 3 times a day of the second medication (10 patients received each medication), they were challenged once more 16 h after the last dose." | 6.66 | Comparison of tremor responses to orally administered albuterol and terbutaline. ( Druz, WS; Jenne, JW; Shaughnessy, TK; Starkey, PW; Valcarenghi, G; Yu, C, 1986) |
| "Patients with gastroesophageal reflux disease may have pulmonary symptoms due to repeated aspiration of gastric contents or reflex bronchospasm during a reflux event." | 5.28 | The effects of inhaled albuterol and oral theophylline on gastroesophageal reflux in patients with gastroesophageal reflux disease and obstructive lung disease. ( Austin, J; Rohwedder, JJ; Ruzkowski, CJ; Sanowski, RA; Waring, JP, 1992) |
| "We tested the hypothesis that the decrease in dyspnea in patients with COPD with inhaled albuterol is in part due to increased diaphragmatic contractility." | 5.09 | Does inhaled albuterol improve diaphragmatic contractility in patients with chronic obstructive pulmonary disease? ( Hatipoğlu, U; Laghi, F; Tobin, MJ, 1999) |
| " The efficacy, safety and tolerability of the Novolizer has been compared with those of established inhalational devices for the delivery of salbutamol (Sultanol) in patients with chronic obstructive pulmonary disease and for the administration of budesonide (Pulmicort Turbuhaler) to patients with asthma." | 5.09 | Therapeutic equivalence of the Sofotec Novolizer to established standard devices in COPD and asthma. ( Chuchalin, AG; Kunkel, G, 2001) |
| "To evaluate the impact of a week-long course of inhaled albuterol compared with ipratropium on expiratory peak flow, exercise performance, and dyspnea in patients with stable COPD." | 5.08 | Is an anticholinergic agent superior to a beta 2-agonist in improving dyspnea and exercise limitation in COPD? ( Blosser, SA; Localio, AR; Maxwell, SL; Reeves-Hoche, MK; Zwillich, CW, 1995) |
| " The effect of theophylline and salbutamol, alone or combined, on pulmonary function and dyspnea during daily activities was examined." | 5.07 | Mechanism of bronchodilator effect in chronic airflow limitation. ( Guyatt, GH; Jaeschke, R; Keller, J; Newhouse, MT; Singer, J, 1991) |
| "We compared the frequency and severity of cardiac arrhythmias during combined oral theophylline and inhaled salbutamol vs." | 5.06 | Theophylline and salbutamol in combination in patients with obstructive pulmonary disease and concurrent heart disease: effect on cardiac arrhythmias. ( Huikuri, H; Korhonen, UR; Linnaluoto, M; Poukkula, A, 1989) |
| "In 12 adult patients with reversible bronchospasm (7 bronchial asthma and 5 chronic obstructive bronchitis) the bronchodilator activity and tolerability of 200 and 400 mcg of broxaterol hydrochloride (Z 1170) were compared to those of 200 mcg of salbutamol administered by metered-dose inhaler." | 5.06 | A comparison of the bronchodilator effects of broxaterol and salbutamol. ( Casali, L; Colombo, ML; Manazza, P; Rossi, A; Zoia, MC, 1988) |
| "In a single-blind placebo-controlled trial in 12 patients with advanced chronic obstructive pulmonary disease (COPD) we compared the effects of nebulized salbutamol (1 mg), clenbuterol (30 micrograms) and placebo (4 ml of normal saline) on spirometric indices (FVC, FEV1), maximal expiratory flows (Vmax50 and Vmax25), the distance walked in 6 min (6MD), assessment of breathlessness by visual analogue scale (VAS), and estimates by the patients of perceived exertion (RPE)." | 5.06 | Effects of beta-agonists on breathlessness and exercise tolerance in patients with chronic obstructive pulmonary disease. ( Galavotti, V; Papiris, S; Sturani, C, 1986) |
| " The suggestion is made that failure to recognize the nonlinearity of the dose-response curves for bronchodilators has resulted in underestimating their combined action." | 3.76 | Theophylline as a bronchodilator in COPD and its combination with inhaled beta-adrenergic drugs. ( Jenne, JW, 1987) |
| "The purpose of this study was to observe the effectiveness of lidocaine in suppressing cough which is a logical extension of its established use in bronchoscopy." | 3.71 | Lidocaine inhalation for cough suppression. ( Udezue, E, 2001) |
| "We describe the occurrence of sudden severe bronchospasm and respiratory arrest following dipyridamole infusion in a patient with chronic obstructive pulmonary disease predominantly of the emphysematous type." | 3.67 | Severe bronchospasm followed by respiratory arrest during thallium-dipyridamole imaging. ( Cerino, M; Laverdiere, M; Lette, J; Prenovault, J; Tremblay, J, 1989) |
| "To determine whether asthma alone can cause irreversible airflow obstruction 42 men and 47 women with chronic asthma (mean duration 22 (SD 13) years) without evidence of other disease likely to cause irreversible airflow obstruction were treated with theophylline orally and a beta agonist both orally and by inhalation for four weeks." | 3.67 | Asthma and irreversible airflow obstruction. ( Brown, PJ; Finucane, KE; Greville, HW, 1984) |
| " We measured breathlessness at rest, using a Borg scale dyspnea index (BSDI) before and after bronchodilator albuterol [salbutamol] 200 micrograms) in 93 patients with OLD drawn from a larger population undergoing routine spirometry." | 3.67 | The relationship between pulmonary function and dyspnea in obstructive lung disease. ( Colacone, A; Dajczman, E; Kreisman, H; Wolkove, N, 1989) |
| "The concentrations of theophylline, terbutaline and salbutamol in post-mortem blood samples from 68 patients (17-85 years old) with asthma or chronic obstructive lung disease, 54 of whom had died of asthma, were analysed." | 3.67 | Post-mortem concentrations of salbutamol, terbutaline and theophylline in asthma patients. ( Boman, G; Lindsjö, M; Lindström, B; Strandberg, K; Wiholm, BE, 1987) |
| " Pre- and post-treatment vital signs did not differ between groups, but use of the BAN was associated with a shorter duration and a lower occurrence of adverse events." | 2.77 | A prospective, comparative trial of standard and breath-actuated nebulizer: efficacy, safety, and satisfaction. ( Arunthari, V; Bruinsma, RS; Johnson, MM; Lee, AS, 2012) |
| "Cumulative dosing with albuterol HFA 180 microg or 360 microg via MDI-spacer and face mask in children younger than 2 years did not result in any significant safety issues and improved MTASS by at least 48%." | 2.75 | Repeat dosing of albuterol via metered-dose inhaler in infants with acute obstructive airway disease: a randomized controlled safety trial. ( Davis, AM; Ellsworth, A; Goodman, B; Kaashmiri, M; Lincourt, WR; Shepard, J; Trivedi, R, 2010) |
| " The long duration of action of salmeterol offers the advantage of twice daily dosing compared with the required four times a day dosing with ipratropium." | 2.70 | Use of a long-acting inhaled beta2-adrenergic agonist, salmeterol xinafoate, in patients with chronic obstructive pulmonary disease. ( Anderson, W; Bailey, W; Broughton, J; Friedman, M; Rennard, SI; Rickard, K; Wisniewski, M; ZuWallack, R, 2001) |
| " Assessment of 1-second forced expiratory volume (FEV1) curves before and after dosing on the last day of each 2-week period indicated that the combination was superior to either single agent in peak effect and area under the curve up to 8 h after dosing (FEV1-AUC0-8), in both phases of the trial." | 2.69 | Inhalation by nebulization of albuterol-ipratropium combination (Dey combination) is superior to either agent alone in the treatment of chronic obstructive pulmonary disease. Dey Combination Solution Study Group. ( Coleman, W; Gross, N; Linberg, S; Miller, R; Oren, J; Tashkin, D, 1998) |
| " Each agent was given in recommended dosage on separate days in a double-blind, crossover format, and the patients' arterial blood gases (ABGs) were measured at baseline and at intervals to 120 min." | 2.69 | Effects of salmeterol on arterial blood gases in patients with stable chronic obstructive pulmonary disease. Comparison with albuterol and ipratropium. ( Gross, NJ; Khoukaz, G, 1999) |
| "This study shows that acute pretreatment with 50 microg salmeterol does not block the possibility of inducing more bronchodilation with an anticholinergic agent when a higher than normal dosage of the muscarinic antagonist is used." | 2.69 | Acute effect of pretreatment with single conventional dose of salmeterol on dose-response curve to oxitropium bromide in chronic obstructive pulmonary disease. ( Califano, C; Cazzola, M; Centanni, S; D'Amato, G; D'Amato, M; Di Perna, F; Donner, CF, 1999) |
| " Frequent adverse events were exacerbations of the underlying airway disease (24%) and infections (12%), while typical pharmacological side-effects like tremor or tachycardia where reported in less than 1% of all patients." | 2.69 | [efficacy and safety of salmeterol in long-term therapy in patients with chronic obstructive airway diseases]. ( Beeh, KM; Buhl, R; Salem, AE; Wiewrodt, R, 2000) |
| "Dyspnea is a common complaint during daily activities in patients with advanced COPD." | 2.69 | The cumulative effect of long-acting bronchodilators, exercise, and inspiratory muscle training on the perception of dyspnea in patients with advanced COPD. ( Berar-Yanay, N; Davidovich, A; Magadle, R; Weiner, M; Weiner, P, 2000) |
| "The present study was designed to evaluate the bronchodilating role of zafirlukast, a CysLT(1)receptor antagonist, at the standard dosage currently recommended in the marketing of this agent in smokers with COPD." | 2.69 | Lung function improvement in smokers suffering from COPD with zafirlukast, a CysLT(1)-receptor antagonist. ( Allegra, L; Boveri, B; Carlucci, P; Cazzola, M; Centanni, S; DiMarco, F; Santus, P, 2000) |
| " At each visit, a dose-response curve to inhaled salbutamol was constructed using a total cumulative dose of 800 microg." | 2.69 | Additive effects of salmeterol and fluticasone or theophylline in COPD. ( Calderaro, F; Cazzola, M; Centanni, S; Di Lorenzo, G; Di Perna, F; Testi, R, 2000) |
| "We examined whether a pretreatment with formoterol, oxitropium bromide, or salmeterol might modify the dose-response curves to inhaled salbutamol in patients with stable and partially reversible chronic obstructive pulmonary disease (COPD)." | 2.69 | Effects of formoterol, salmeterol or oxitropium bromide on airway responses to salbutamol in COPD. ( Calderaro, F; Cazzola, M; Di Perna, F; Girbino, G; Matera, MG; Noschese, P; Vinciguerra, A, 1998) |
| "When testing the response to beta 2-agonist drugs in severe chronic obstructive pulmonary disease (COPD), a dose-response assessment should be undertaken." | 2.68 | Salmeterol and formoterol in partially reversible severe chronic obstructive pulmonary disease: a dose-response study. ( Cazzola, M; D'Amato, G; Matera, MG; Rossi, F; Santangelo, G; Vinciguerra, A, 1995) |
| "Zardaverine is a selective inhibitor of phosphodiesterase (PDE) III and IV isozymes." | 2.68 | Effects of the mixed phosphodiesterase III/IV inhibitor, zardaverine, on airway function in patients with chronic airflow obstruction. ( Reiber, C; Rentz, K; Sybrecht, GW; Ukena, D, 1995) |
| " In conclusion, combining the standard dosages of ipratropium bromide and salbutamol may provide greater bronchodilation than doubling the standard dosage of ipratropium bromide in patients with COPD." | 2.68 | Bronchodilating effects of combined therapy with clinical dosages of ipratropium bromide and salbutamol for stable COPD: comparison with ipratropium bromide alone. ( Ikeda, A; Izumi, T; Koyama, H; Nishimura, K, 1995) |
| "Comparisons of breathlessness, exercise volumes, and pressures were made at the highest equivalent work load." | 2.68 | Inhaled bronchodilators reduce dynamic hyperinflation during exercise in patients with chronic obstructive pulmonary disease. ( Belman, MJ; Botnick, WC; Shin, JW, 1996) |
| " The longer dosing intervals, which may enhance compliance, encourage its administration in patients with COPD." | 2.68 | A comparison of the bronchodilating effects of salmeterol, salbutamol and ipratropium bromide in patients with chronic obstructive pulmonary disease. ( Calderaro, F; Caputi, M; Cazzola, M; Di Perna, F; Matera, MG; Rossi, F; Vinciguerra, A, 1995) |
| "Dyspnea was measured by the -5 to +5 category scale at rest and by the 0 to 10 category-ratio scale while breathing through inspiratory resistances of 5, 15, and 30 cm H20/L/s." | 2.68 | Salmeterol reduces dyspnea and improves lung function in patients with COPD. ( Lentine, T; Mahler, DA; Ramirez-Venegas, A; Ward, J, 1997) |
| "Salmeterol produced a small increase in FEV1 at one and six hours after a single dose, and this was maintained after chronic dosing (mean difference and 95% CI versus placebo): single dosing at one hour 0." | 2.68 | Effects of regular salmeterol on lung function and exercise capacity in patients with chronic obstructive airways disease. ( Dhillon, DP; Grove, A; Ingram, CG; Jenkins, RJ; Lipworth, BJ; Ramage, L; Reid, P; Smith, RP; Winter, JH, 1996) |
| "Oral theophylline treatment causes a sustained increase in resting oxygen consumption and heart rate but does not modify the metabolic response to acutely inhaled salbutamol." | 2.67 | Effect of oral theophylline on resting energy expenditure in normal volunteers. ( Agrawal, A; Dash, A; Moxham, J; Ponte, J; Venkat, N, 1994) |
| "Supraventricular arrhythmias were common on both saline and salbutamol days (8 vs." | 2.67 | Effect of high-dose salbutamol on cardiac rhythm in severe chronic airflow obstruction: a controlled study. ( Hall, IP; Johnston, ID; Woodhead, MA, 1994) |
| " This study shows that the additive bronchodilating effect of theophylline, when used in combination with salbutamol, 200 micrograms, and ipratropium, 40 micrograms, is significant but small in stable COPD." | 2.67 | Is oral theophylline effective in combination with both inhaled anticholinergic agent and inhaled beta 2-agonist in the treatment of stable COPD? ( Ikeda, A; Izumi, T; Koyama, H; Nishimura, K, 1993) |
| " Safety was determined by monitoring adverse events and standard biochemical, haematological and cardiovascular parameters." | 2.67 | Inhaled salmeterol in the treatment of patients with moderate to severe reversible obstructive airways disease--a 3-month comparison of the efficacy and safety of twice-daily salmeterol (100 micrograms) with salmeterol (50 micrograms). ( Palmer, JB; Shepherd, GL; Stuart, AM; Viskum, K, 1992) |
| " Thirty-two patients requested home nebulizer treatment for long-term use (nine salbutamol, five IB, 18 mixture)." | 2.67 | A long-term prospective assessment of home nebulizer treatment. ( Bernstein, A; Chetty, MC; Kay, EA; O'Driscoll, BR; Taylor, RJ; Weatherby, H, 1992) |
| " To determine whether these drugs also protect against excessive airway narrowing, the effect of inhaled salbutamol on the position and shape of the dose-response curves for histamine or methacholine was investigated in 12 patients with asthma and 11 with chronic obstructive lung disease." | 2.67 | The protective effect of a beta 2 agonist against excessive airway narrowing in response to bronchoconstrictor stimuli in asthma and chronic obstructive lung disease. ( Bel, EH; Dijkman, JH; Sterk, PJ; Timmers, MC; Zwinderman, AH, 1991) |
| "Cardioselectivity of a single oral dose of metoprolol oral osmotic (OROS) (14/190 mg) and atenolol (100 mg) was compared in 12 patients with reversible obstructive airway disease by assessing the dose-response curve to increasing doses of inhaled salbutamol." | 2.67 | Comparative evaluation of cardioselectivity of metoprolol OROS and atenolol: a double-blind, placebo-controlled crossover study. ( Bruni, B; Dottorini, ML; Grassi, V; Lecaillon, JB; Motolese, M; Peccini, F; Sorbini, CA; Tantucci, C, 1990) |
| "Patients with severe chronic airways obstruction often respond poorly to inhaled salbutamol in conventional dosage from a pressurized aerosol." | 2.66 | High dose salbutamol in chronic airflow obstruction: comparison of nebulizer with Rotacaps. ( Assoufi, BK; Hodson, ME, 1989) |
| "Doxofylline was better tolerated than theophylline considering either the number of unwanted side-effects: (doxofylline 12; theophylline 37) or number of drop-outs due to side-effects (doxofylline 5; theophylline 10)." | 2.66 | Treatment of reversible chronic airways obstruction with doxofylline compared with slow-release theophylline: a double-blind, randomized, multicentre trial. ( Balzano, G; Campisi, V; Capone, M; De Felice, A; Di Filippo, A; Foddai, G; Franzone, JS; Grossi, E; Jodice, F; Melillo, G, 1989) |
| " Dose-response curves were obtained for inhaled salbutamol and inhaled ipratropium bromide." | 2.66 | Effect of three different bronchodilators during an exacerbation of chronic obstructive pulmonary disease. ( Agusti-Vidal, A; Campistol, J; Lloberes, P; Montserrat, JM; Picado, C; Ramis, L; Serra, J, 1988) |
| "It is likely that arrhythmias may be precipitated in patients with hypoxaemia, acidosis or those with preexisting cardiovascular disease." | 2.66 | Hypokalaemic and electrocardiographic effects of aminophylline and salbutamol in obstructive airways disease. ( Burgess, CD; Crane, J; Graham, AN; Maling, TJ, 1987) |
| "Aminophylline was administered intravenously as a bolus and an infusion for 150 minutes." | 2.66 | The hemodynamic effects of aminophylline and salbutamol alone and in combination. ( Burgess, CD; Crane, J; Graham, AN; Maling, TJ, 1986) |
| " The doses of salbutamol inhaled via the nebulizer and MDI producing maximal bronchodilation were established by cumulative dose-response curves." | 2.66 | Comparison of domiciliary nebulized salbutamol and salbutamol from a metered-dose inhaler in stable chronic airflow limitation. ( Fulton, TJ; Heaton, RW; Jenkins, SC; Moxham, J, 1987) |
| " Then after a further 3 wk of dosing 3 times a day of the second medication (10 patients received each medication), they were challenged once more 16 h after the last dose." | 2.66 | Comparison of tremor responses to orally administered albuterol and terbutaline. ( Druz, WS; Jenne, JW; Shaughnessy, TK; Starkey, PW; Valcarenghi, G; Yu, C, 1986) |
| "Theophylline or placebo was then administered every 12 hours with crossover after 6 weeks." | 2.66 | Long-term therapy with sustained-release theophylline. ( Arnulf, V; Myhre, KI; Walstad, RA, 1985) |
| " These results suggest a better bioavailability of Th, likely accounted for by a more advanced pharmaceutical technology." | 2.66 | Serum theophylline and ventilatory function in chronic obstructive lung disease. Comparison between two slow-release formulations of theophylline. ( Cornelli, U; Grassi, V; Sorbini, CA; Tantucci, C; Verdecchia, P, 1985) |
| " Analysis of variance of the results indicated significant dose-response relationships and showed the larger doses to have a longer duration of action." | 2.65 | Dose-response study of inhaled salbutamol powder in chronic airflow obstruction. ( Corris, PA; Gibson, GJ; Nariman, S; Neville, E, 1983) |
| "Aminophylline did not cause tachycardia and this difference compared with the beta-agonists on pulse rate was statistically significant (p less than 0." | 2.65 | Comparative study of the effects of intravenous administration of aminophylline, salbutamol and terbutaline in patients suffering from reversible airways obstruction. ( Bell, R; Chatterjee, SS; Jayaswal, R; Sahay, JN, 1984) |
| " Increase of dosage did not lead to improved effectiveness." | 2.65 | [Parasympathicolytic drugs in treatment of obstructive lung diseases (author's transl)]. ( Gonsior, E; Meier-Sydow, J; Schultze-Werninghaus, G, 1979) |
| "Patients with gastroesophageal reflux disease may have pulmonary symptoms due to repeated aspiration of gastric contents or reflex bronchospasm during a reflux event." | 1.28 | The effects of inhaled albuterol and oral theophylline on gastroesophageal reflux in patients with gastroesophageal reflux disease and obstructive lung disease. ( Austin, J; Rohwedder, JJ; Ruzkowski, CJ; Sanowski, RA; Waring, JP, 1992) |
| " Although the number of subjects studied is small, our data suggest that air-driven nebulised high-dose salbutamol may be safe in the treatment of severe chronic obstructive airway disease but when combined with oral theophylline, a significant fall in plasma potassium may occur." | 1.28 | Air-driven nebulised high-dose salbutamol in severe chronic obstructive airways disease: is it safe? ( Friend, JA; Lai, CK; Legge, JS, 1991) |
| "Albuterol was effective in increasing the PEFR in patients with asthma, COPD and NANC." | 1.28 | The prehospital use of nebulized albuterol on patients with wheezing whose chief complaint is shortness of breath. ( Dickinson, ET; Megargel, R; O'Connor, RE, 1992) |
| " Dose-response curves were measured after three weeks of treatment with ipratropium bromide and again after a three-week course of inhaled salbutamol." | 1.28 | Tolerance to beta 2-agonists in patients with chronic obstructive pulmonary disease. ( Anthonisen, NR; Georgopoulos, D; Wong, D, 1990) |
| "Recently, it was suggested that long-term administration of an inhaled beta 2-agonist might increase bronchial hyperresponsiveness (BHR) to histamine, possibly as a consequence of subsensitization to the inhaled beta 2-agonist." | 1.28 | Increased bronchial hyperresponsiveness after inhaling salbutamol during 1 year is not caused by subsensitization to salbutamol. ( Dompeling, E; Graafsma, SJ; van Herwaarden, CL; van Schayck, CP; van Weel, C; Visch, MB, 1990) |
| "A total of 203 patients with chronic obstructive pulmonary diseases (COPD) with normal blood pressure (BP) as well as with systemic arterial hypertension of different character (labile and stable pulmonogenic essential hypertension) were examined." | 1.27 | [Chronic obstructive lung diseases associated with systemic arterial hypertension]. ( Konovalov, VI; Kubyshkin, VF; Soldatchenko, SS, 1985) |
| " Both contractile cholinergic responses and relaxant nonadrenergic noncholinergic dose-response data were obtained for the in vitro bronchial specimens by electrical field stimulation." | 1.27 | Airway reactivity in chronic obstructive pulmonary disease. Failure of in vivo methacholine responsiveness to correlate with cholinergic, adrenergic, or nonadrenergic responses in vitro. ( Armour, CL; Hogg, JC; Paré, PD; Schellenberg, RR; Taylor, SM, 1985) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 142 (35.32) | 18.7374 |
| 1990's | 195 (48.51) | 18.2507 |
| 2000's | 55 (13.68) | 29.6817 |
| 2010's | 10 (2.49) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bar-Aluma, BE | 1 |
| Efrati, O | 1 |
| Kaufmann, H | 1 |
| Palma, JA | 1 |
| Norcliffe-Kaufmann, L | 1 |
| Loborec, SM | 1 |
| Johnson, SE | 1 |
| Keating, EA | 1 |
| Czövek, D | 1 |
| Shackleton, C | 1 |
| Hantos, Z | 1 |
| Taylor, K | 1 |
| Kumar, A | 1 |
| Chacko, A | 1 |
| Ware, RS | 1 |
| Makan, G | 1 |
| Radics, B | 1 |
| Gingl, Z | 1 |
| Sly, PD | 1 |
| Arroyo, MG | 1 |
| Couëtil, LL | 1 |
| Nogradi, N | 1 |
| Kamarudin, MM | 1 |
| Ivester, KM | 1 |
| McCartney, CT | 1 |
| Weis, MN | 1 |
| Ruppel, GL | 1 |
| Nayak, RP | 1 |
| Lowe, DO | 1 |
| Lummis, H | 1 |
| Zhang, Y | 1 |
| Sketris, IS | 1 |
| Thamrin, C | 1 |
| Stern, G | 1 |
| Strippoli, MP | 1 |
| Kuehni, CE | 1 |
| Suki, B | 1 |
| Taylor, DR | 2 |
| Frey, U | 1 |
| Kaashmiri, M | 1 |
| Shepard, J | 1 |
| Goodman, B | 1 |
| Lincourt, WR | 1 |
| Trivedi, R | 1 |
| Ellsworth, A | 1 |
| Davis, AM | 1 |
| DiBlasi, RM | 1 |
| Coppolo, DP | 1 |
| Nagel, MW | 1 |
| Doyle, CC | 1 |
| Avvakoumova, VI | 1 |
| Ali, RS | 1 |
| Mitchell, JP | 1 |
| Matera, MG | 10 |
| Calzetta, L | 1 |
| Rogliani, P | 1 |
| Bardaro, F | 1 |
| Page, CP | 1 |
| Cazzola, M | 13 |
| Arunthari, V | 1 |
| Bruinsma, RS | 1 |
| Lee, AS | 1 |
| Johnson, MM | 1 |
| Ari, A | 1 |
| Fink, JB | 2 |
| Appleton, S | 3 |
| Poole, P | 4 |
| Smith, B | 3 |
| Veale, A | 3 |
| Bara, A | 2 |
| Sestini, P | 3 |
| Renzoni, E | 2 |
| Robinson, S | 2 |
| Ram, FS | 3 |
| Mazan, MR | 1 |
| Hoffman, AM | 1 |
| Kuehn, H | 1 |
| Deveney, EF | 1 |
| Schleufe, P | 1 |
| Domurath, H | 1 |
| Piepenbrock, S | 1 |
| Halvorsen, T | 1 |
| Skadberg, BT | 1 |
| Eide, GE | 1 |
| Røksund, OD | 1 |
| Carlsen, KH | 1 |
| Bakke, P | 1 |
| Hirsch, W | 1 |
| Sorge, I | 1 |
| Schlüter, A | 1 |
| Eichler, G | 1 |
| Wenkel, R | 1 |
| Lasserson, TJ | 1 |
| Chan, MM | 1 |
| Mitchell, DM | 1 |
| Gildeh, P | 1 |
| Rehahn, M | 1 |
| Dimond, AH | 1 |
| Collins, JV | 1 |
| Montanari, S | 1 |
| Pasqua, F | 1 |
| Gramiccioni, E | 2 |
| Curzon, PG | 1 |
| Martin, MA | 1 |
| Cooke, NJ | 1 |
| Muers, MF | 4 |
| Brown, IG | 1 |
| Chan, CS | 1 |
| Kelly, CA | 1 |
| Dent, AG | 1 |
| Zimmerman, PV | 1 |
| Tang, OT | 1 |
| Flatley, M | 1 |
| Jolobe, OM | 2 |
| Greco, N | 2 |
| Tosto, L | 2 |
| Shah, SS | 1 |
| Johnston, D | 1 |
| Woodcock, AA | 1 |
| Johnson, M | 2 |
| Geddes, DM | 1 |
| Lahdensuo, A | 1 |
| Sovijärvi, A | 1 |
| Muittari, A | 1 |
| Jaffé, G | 1 |
| Grimshaw, JJ | 1 |
| Sahay, JN | 1 |
| Bell, R | 1 |
| Chatterjee, SS | 1 |
| Jayaswal, R | 1 |
| Maesen, FP | 2 |
| Smeets, JJ | 1 |
| Bernsen, R | 1 |
| Cornelissen, PJ | 1 |
| Gunawardena, KA | 1 |
| Ebden, P | 2 |
| Higgins, DA | 1 |
| Campbell, IA | 1 |
| Kaik, G | 3 |
| Kaik, B | 1 |
| Jenkins, CR | 1 |
| Chow, CM | 1 |
| Fisher, BL | 1 |
| Marlin, GE | 1 |
| Housset, B | 2 |
| Boitier, JF | 1 |
| Fleury, B | 1 |
| De L'Homme, G | 1 |
| Kulpa, M | 1 |
| Medrano, G | 1 |
| Derenne, JP | 2 |
| Harrison, BA | 1 |
| Pierce, RJ | 1 |
| Lawford, P | 1 |
| McKenzie, D | 1 |
| Shim, CS | 1 |
| Williams, MH | 1 |
| Larsson, S | 1 |
| Brown, PJ | 1 |
| Greville, HW | 1 |
| Finucane, KE | 1 |
| Lafortuna, CL | 1 |
| Fazio, F | 1 |
| Brändli, O | 1 |
| Langloh, P | 1 |
| Middleton, E | 1 |
| Neville, E | 2 |
| Corris, PA | 3 |
| Vivian, J | 1 |
| Nariman, S | 2 |
| Gibson, GJ | 3 |
| Arnup, ME | 1 |
| Mendella, LA | 1 |
| Anthonisen, NR | 5 |
| Chryssidis, E | 1 |
| Frewin, DB | 1 |
| Frith, PA | 1 |
| Dawes, ER | 1 |
| Wilson, RS | 1 |
| Connellan, SJ | 2 |
| Tanser, AR | 1 |
| Tal, A | 1 |
| Bar-Yishay, E | 1 |
| Eyal, F | 1 |
| Godfrey, S | 1 |
| Barber, AR | 1 |
| Redmond, JV | 1 |
| Starke, ID | 1 |
| Parker, RA | 1 |
| Turner-Warwick, M | 1 |
| Gough, SE | 1 |
| Barclay, J | 1 |
| Whiting, B | 1 |
| Addis, GJ | 1 |
| Bassein, L | 1 |
| Iodice, F | 1 |
| Rufolo, L | 1 |
| Piscione, F | 1 |
| De Michele, G | 1 |
| Crawford, SM | 1 |
| Miles, DW | 1 |
| Mayer, K | 1 |
| van der Ploeg, RJ | 1 |
| Tolhoek, HJ | 1 |
| Akkerboom, JC | 1 |
| Knol, K | 1 |
| Falliers, CJ | 1 |
| Iaia, E | 1 |
| Cagnazzo, R | 1 |
| Digilio, VS | 1 |
| Scoditti, A | 1 |
| Sevieri, GP | 1 |
| Quartieri, F | 1 |
| Del Bono, N | 1 |
| Clark, CJ | 1 |
| Boyd, G | 4 |
| Nolte, D | 1 |
| Steffensen, I | 1 |
| Faurschou, P | 2 |
| Riska, H | 1 |
| Rostrup, J | 1 |
| Wegener, T | 2 |
| Beusenberg, FD | 2 |
| Hoogsteden, HC | 2 |
| Bonta, IL | 2 |
| van Amsterdam, JG | 2 |
| Cukier, A | 1 |
| Vargas, FS | 1 |
| Teixeira, LR | 1 |
| Grupi, CJ | 1 |
| Terra-Filho, M | 1 |
| Carvalho-Pinto, RM | 1 |
| Light, RW | 2 |
| Ulrik, CS | 2 |
| Moayyedi, P | 1 |
| Congleton, J | 2 |
| Page, RL | 2 |
| Pearson, SB | 2 |
| Zehner, WJ | 1 |
| Scott, JM | 1 |
| Iannolo, PM | 1 |
| Ungaro, A | 1 |
| Terndrup, TE | 1 |
| Zerah, F | 2 |
| Lorino, AM | 2 |
| Lorino, H | 3 |
| Harf, A | 3 |
| Macquin-Mavier, I | 1 |
| Santangelo, G | 2 |
| Vinciguerra, A | 6 |
| Rossi, F | 3 |
| D'Amato, G | 4 |
| Ukena, D | 1 |
| Rentz, K | 1 |
| Reiber, C | 1 |
| Sybrecht, GW | 1 |
| Blosser, SA | 1 |
| Maxwell, SL | 1 |
| Reeves-Hoche, MK | 1 |
| Localio, AR | 1 |
| Zwillich, CW | 1 |
| Chang, JT | 1 |
| Moran, MB | 1 |
| Cugell, DW | 1 |
| Webster, JR | 1 |
| Chuchalin, AG | 2 |
| Tsoĭ, AN | 1 |
| Zaĭtseva, TM | 1 |
| Titova, EV | 1 |
| Medani, SM | 1 |
| Smirnov, MV | 1 |
| Kaziakhmedov, EA | 1 |
| Cydulka, RK | 2 |
| Emerman, CL | 2 |
| Petty, TL | 3 |
| Friedman, M | 3 |
| Hansen, NC | 1 |
| Andersen, PB | 1 |
| Smeenk, G | 1 |
| Burgers, GJ | 1 |
| Teunissen, PC | 1 |
| van Schayck, CP | 4 |
| Dompeling, E | 3 |
| Rutten, MP | 1 |
| Folgering, H | 3 |
| van den Boom, G | 1 |
| van Weel, C | 4 |
| Dhand, R | 2 |
| Jubran, A | 2 |
| Tobin, MJ | 3 |
| Vizel', AA | 2 |
| Iaushev, MF | 1 |
| Mustafin, RR | 1 |
| Goncharova, LV | 1 |
| Stålenheim, G | 2 |
| Grettve, L | 1 |
| Lundbäck, B | 1 |
| Melander, B | 1 |
| Osterman, K | 1 |
| Piitulainen, E | 1 |
| Zetterström, O | 1 |
| Dash, A | 1 |
| Agrawal, A | 1 |
| Venkat, N | 1 |
| Moxham, J | 2 |
| Ponte, J | 1 |
| Malerba, M | 1 |
| Boni, E | 1 |
| Romagnoni, G | 1 |
| Filippi, B | 1 |
| Politi, A | 1 |
| Giustina, A | 1 |
| Tantucci, C | 4 |
| Grassi, V | 3 |
| Ikeda, A | 6 |
| Nishimura, K | 8 |
| Koyama, H | 7 |
| Izumi, T | 8 |
| Sugiura, N | 2 |
| Kawakatsu, K | 1 |
| Piccolo, A | 1 |
| Salzillo, A | 2 |
| Wassermann, K | 1 |
| Pothoff, G | 1 |
| Subbe, C | 1 |
| Bahra, J | 1 |
| Hilger, HH | 1 |
| Goodman, DE | 1 |
| Israel, E | 1 |
| Rosenberg, M | 1 |
| Johnston, R | 1 |
| Weiss, ST | 1 |
| Drazen, JM | 1 |
| Hall, IP | 1 |
| Woodhead, MA | 1 |
| Johnston, ID | 1 |
| Mio, T | 2 |
| Van Noord, JA | 3 |
| Smeets, J | 1 |
| Clément, J | 1 |
| Van de Woestijne, KP | 1 |
| Demedts, M | 1 |
| Dor, A | 1 |
| Krasnowska, M | 1 |
| Małolepszy, J | 1 |
| Holten, K | 2 |
| Lulling, J | 1 |
| Schaaning, J | 1 |
| Vander Straeten, M | 1 |
| Verstraeten, JM | 1 |
| Jaeschke, R | 3 |
| Guyatt, GH | 6 |
| Cook, D | 2 |
| Morris, J | 1 |
| Willan, A | 1 |
| McIlroy, W | 1 |
| Harper, S | 1 |
| Ramsdale, H | 2 |
| Haddon, R | 1 |
| Fitzgerald, MJ | 1 |
| Veale, D | 1 |
| Cooper, BG | 1 |
| Griffiths, CJ | 1 |
| Schmitz, E | 1 |
| Hürter, T | 1 |
| Ochs, JG | 1 |
| Reuber, S | 1 |
| Hanrath, P | 1 |
| Kerstjens, HA | 1 |
| Brand, PL | 2 |
| Quanjer, PH | 1 |
| van der Bruggen-Bogaarts, BA | 1 |
| Koëter, GH | 2 |
| Postma, DS | 2 |
| Kesten, S | 1 |
| Rebuck, AS | 1 |
| Karpel, JP | 1 |
| Kotch, A | 1 |
| Zinny, M | 1 |
| Pesin, J | 1 |
| Alleyne, W | 1 |
| Vetto, TA | 1 |
| Moore, GP | 1 |
| Geraghty, R | 1 |
| Foster, C | 1 |
| Black, D | 1 |
| Roe, S | 1 |
| Nanz, S | 1 |
| Imhof, E | 2 |
| Elsasser, S | 1 |
| Karrer, W | 1 |
| Grossenbacher, M | 1 |
| Emmons, R | 1 |
| Perruchoud, AP | 2 |
| Tandon, MK | 1 |
| Coe, CI | 1 |
| Pride, NB | 1 |
| Hansen, JE | 1 |
| Casaburi, R | 2 |
| Goldberg, AS | 1 |
| Hugli, O | 1 |
| Schutz, Y | 2 |
| Fitting, JW | 2 |
| Hendrick, DJ | 1 |
| Ingram, RH | 1 |
| Vollmer, M | 2 |
| Schmidt, EW | 2 |
| Ulmer, WT | 3 |
| Colice, GL | 1 |
| Levin, DC | 1 |
| Little, KS | 1 |
| Laughlin, KR | 1 |
| Galbraith, JM | 1 |
| Gustman, PM | 1 |
| Murphy, D | 1 |
| Kram, JA | 1 |
| Hardie, G | 1 |
| Reuter, C | 1 |
| Ostransky, D | 1 |
| McFarland, K | 1 |
| Silvers, W | 1 |
| Rennard, SI | 2 |
| Mueller, M | 1 |
| Repsher, LH | 1 |
| Zuwallack, RL | 2 |
| Vale, R | 1 |
| Ahmad, HR | 2 |
| Khan, MA | 2 |
| Memon, M | 1 |
| Khan, MN | 1 |
| Belman, MJ | 1 |
| Botnick, WC | 1 |
| Shin, JW | 1 |
| Pingleton, SK | 1 |
| Chazan, R | 1 |
| Jaworski, A | 1 |
| Grubek-Jaworska, H | 1 |
| Droszcz, W | 3 |
| Lipworth, BJ | 4 |
| Charoenratanakul, S | 2 |
| Borrirukwanit, K | 2 |
| Martin, W | 1 |
| Unützer, J | 1 |
| Szuba, MP | 1 |
| Duarte, AG | 2 |
| Jenne, JW | 3 |
| Fahey, PJ | 1 |
| Terzano, C | 1 |
| Mannino, F | 2 |
| Joyce, DP | 1 |
| Teramoto, S | 2 |
| Fukuchi, Y | 1 |
| Ouchi, Y | 2 |
| Healey, D | 1 |
| Man, GC | 1 |
| Champman, KR | 1 |
| Ali, SH | 1 |
| Darke, AC | 1 |
| Di Perna, F | 7 |
| Calderaro, F | 6 |
| Caputi, M | 2 |
| Turner, MO | 1 |
| Gafni, A | 1 |
| Swan, D | 1 |
| FitzGerald, JM | 1 |
| Yang, CT | 1 |
| Lin, HC | 1 |
| Lin, MC | 1 |
| Wang, CH | 1 |
| Lee, CH | 1 |
| Kuo, HP | 1 |
| Lekuthai, S | 1 |
| Satayawiwat, W | 1 |
| Dejsomritrutai, W | 1 |
| Clark, DJ | 1 |
| Tan, KS | 1 |
| Grove, A | 1 |
| Reid, P | 1 |
| Smith, RP | 1 |
| Ramage, L | 1 |
| Ingram, CG | 1 |
| Jenkins, RJ | 1 |
| Winter, JH | 1 |
| Dhillon, DP | 1 |
| Rayani, HH | 1 |
| Vellani, CW | 1 |
| Zaidi, SR | 1 |
| D'Angelo, E | 1 |
| Milic-Emili, J | 2 |
| Marazzini, L | 1 |
| Zanen, P | 1 |
| Go, LT | 1 |
| Lammers, JW | 1 |
| Steffensen, IE | 1 |
| Mariette, C | 1 |
| Burdet, L | 1 |
| de Muralt, B | 1 |
| Vichitvejpaisal, P | 1 |
| Joshi, GP | 1 |
| Kumar, S | 1 |
| White, PF | 1 |
| Pellegrino, R | 1 |
| Brusasco, V | 1 |
| Villani, F | 1 |
| De Maria, P | 1 |
| Ronchi, E | 1 |
| Galimberti, M | 1 |
| Jones, PW | 3 |
| Bosh, TK | 1 |
| Morice, AH | 1 |
| Pounsford, JC | 1 |
| Siebert, M | 1 |
| Peslis, N | 1 |
| Crawford, C | 1 |
| Ramirez-Venegas, A | 1 |
| Ward, J | 1 |
| Lentine, T | 1 |
| Mahler, DA | 3 |
| Sridhar, MK | 1 |
| Griffiths, I | 1 |
| Mandelberg, A | 1 |
| Chen, E | 1 |
| Noviski, N | 1 |
| Priel, IE | 1 |
| Wiewrodt, R | 2 |
| Dauletbaev, N | 1 |
| Buhl, R | 2 |
| Szczegielniak, J | 1 |
| Naberan, K | 1 |
| Corden, Z | 1 |
| Rees, PJ | 1 |
| Califano, C | 3 |
| Burdon, J | 1 |
| Jones, R | 1 |
| Johnston, PR | 1 |
| Trowell, SJ | 1 |
| Pillet, O | 1 |
| Manier, G | 1 |
| Castaing, Y | 1 |
| Rossinen, J | 1 |
| Partanen, J | 1 |
| Stenius-Aarniala, B | 1 |
| Nieminen, MS | 1 |
| Noschese, P | 1 |
| Girbino, G | 2 |
| Thomson, NC | 2 |
| Angus, R | 1 |
| Quebe-Fehling, E | 1 |
| Brambilla, R | 1 |
| Mouloudi, E | 4 |
| Katsanoulas, K | 2 |
| Anastasaki, M | 2 |
| Askitopoulou, E | 1 |
| Georgopoulos, D | 6 |
| Imperatore, F | 1 |
| Imperatore, A | 1 |
| Izquierdo-Alonso, JL | 1 |
| Sánchez-Hernández, I | 1 |
| Fernández Francés, J | 1 |
| Castelao Naval, J | 1 |
| Carrillo Arias, F | 1 |
| Gallardo Carrasco, J | 1 |
| Lanes, SF | 1 |
| Lanza, LL | 1 |
| Wentworth, CE | 1 |
| Dekhuijzen, PN | 1 |
| Gross, N | 1 |
| Tashkin, D | 1 |
| Miller, R | 1 |
| Oren, J | 1 |
| Coleman, W | 1 |
| Linberg, S | 1 |
| Creutzberg, EC | 1 |
| Schols, AM | 1 |
| Bothmer-Quaedvlieg, FC | 1 |
| Wesseling, G | 1 |
| Wouters, EF | 3 |
| Törneke, K | 1 |
| Ingvast Larsson, C | 1 |
| Appelgren, LE | 1 |
| Duguet, A | 1 |
| Similowski, T | 1 |
| Zelter, M | 1 |
| Newhouse, MT | 5 |
| Patakas, D | 1 |
| Andreadis, D | 1 |
| Mavrofridis, E | 1 |
| Argyropoulou, P | 1 |
| Campbell, S | 1 |
| Di Pema, F | 1 |
| Donner, CF | 2 |
| Serby, CW | 3 |
| Menjoge, SS | 3 |
| Wilson, JD | 1 |
| Hilleman, DE | 1 |
| Witek, TJ | 4 |
| Muir, JF | 2 |
| Cuvelier, A | 2 |
| Larsen, KR | 1 |
| Svendsen, UG | 1 |
| Mølgaard, F | 1 |
| Petersen, BN | 1 |
| Tsukino, M | 1 |
| Hajiro, T | 1 |
| Mishima, M | 1 |
| Donohue, JF | 2 |
| Barbee, RA | 1 |
| Goldman, MD | 1 |
| Gross, NJ | 2 |
| Wisniewski, ME | 1 |
| Yancey, SW | 1 |
| Zakes, BA | 1 |
| Rickard, KA | 1 |
| Anderson, WH | 1 |
| Dorinsky, PM | 1 |
| Reisner, C | 1 |
| Ferguson, GT | 1 |
| Verbanck, S | 1 |
| Schuermans, D | 1 |
| Noppen, M | 1 |
| Van Muylem, A | 1 |
| Paiva, M | 1 |
| Vincken, W | 1 |
| Teper, AM | 1 |
| Kofman, CD | 1 |
| Maffey, AF | 1 |
| Vidaurreta, SM | 1 |
| Crouch, MA | 1 |
| Raney, CR | 1 |
| Davis, K | 1 |
| Khabibullin, KA | 1 |
| Droszcz, P | 1 |
| Costello, J | 1 |
| Khoukaz, G | 1 |
| Celik, G | 1 |
| Kayacan, O | 1 |
| Beder, S | 1 |
| Durmaz, G | 1 |
| Rutten-van Mölken, M | 1 |
| Roos, B | 1 |
| Richter, K | 1 |
| Holz, O | 1 |
| Jörres, RA | 2 |
| Mücke, M | 1 |
| Magnussen, H | 2 |
| Sanguinetti, CM | 1 |
| Taccola, M | 1 |
| Bancalari, L | 1 |
| Ghignoni, G | 1 |
| Paggiaro, PL | 1 |
| Centanni, S | 3 |
| D'Amato, M | 1 |
| Dahlén, I | 1 |
| Janson, C | 1 |
| Björnsson, E | 1 |
| Peterson, CG | 1 |
| Venge, P | 1 |
| Hatipoğlu, U | 1 |
| Laghi, F | 1 |
| Davies, L | 1 |
| Nisar, M | 3 |
| Pearson, MG | 3 |
| Costello, RW | 1 |
| Earis, JE | 3 |
| Calverley, PM | 4 |
| Nava, S | 1 |
| Navalesi, P | 1 |
| Hoing, S | 1 |
| Hamzaoui, A | 1 |
| Hamzaoui, K | 1 |
| Salah, H | 1 |
| Chabbou, A | 1 |
| Delacourt, C | 1 |
| Herve-Guillot, M | 1 |
| Reinert, P | 1 |
| Manning, HL | 1 |
| Mirza, S | 1 |
| Hopkinson, L | 1 |
| Malik, TH | 1 |
| Willatt, DJ | 1 |
| Koutsogiannis, Z | 1 |
| Kelly, AM | 1 |
| de Munck, DR | 1 |
| Bantje, TA | 1 |
| Hop, WC | 1 |
| Akveld, ML | 1 |
| Bommer, AM | 1 |
| Plant, PK | 1 |
| Owen, JL | 1 |
| Elliott, MW | 1 |
| Rytilä, PH | 1 |
| Lindqvist, AE | 1 |
| Laitinen, LA | 1 |
| Taube, C | 1 |
| Lehnigk, B | 1 |
| Paasch, K | 1 |
| Kirsten, DK | 1 |
| Momii, K | 1 |
| Bidani, A | 1 |
| Campbell, SC | 1 |
| Beeh, KM | 1 |
| Salem, AE | 1 |
| Balzano, G | 2 |
| Battiloro, R | 1 |
| Biraghi, M | 1 |
| Stefanelli, F | 1 |
| Fuschillo, S | 1 |
| Gaudiosi, C | 1 |
| De Angelis, E | 1 |
| Prinianakis, G | 2 |
| Kondili, E | 2 |
| Wade, D | 1 |
| Weiner, P | 1 |
| Magadle, R | 1 |
| Berar-Yanay, N | 1 |
| Davidovich, A | 1 |
| Weiner, M | 1 |
| deBoisblanc, BP | 1 |
| DeBleiux, P | 1 |
| Resweber, S | 1 |
| Fusco, EE | 1 |
| Summer, WR | 1 |
| Michel, O | 1 |
| Olbrecht, J | 1 |
| Moulard, D | 1 |
| Sergysels, R | 2 |
| Boveri, B | 1 |
| Carlucci, P | 1 |
| Santus, P | 1 |
| DiMarco, F | 1 |
| Allegra, L | 1 |
| Papi, A | 1 |
| Romagnoli, M | 1 |
| Baraldo, S | 1 |
| Braccioni, F | 1 |
| Guzzinati, I | 1 |
| Saetta, M | 1 |
| Ciaccia, A | 1 |
| Fabbri, LM | 1 |
| Briggs, DD | 1 |
| Di Lorenzo, G | 1 |
| Testi, R | 1 |
| Guyatt, G | 1 |
| Wong, E | 1 |
| Goldstein, R | 1 |
| Bedard, M | 1 |
| Austin, P | 1 |
| Sears, M | 1 |
| Linder, JA | 1 |
| Stafford, RS | 1 |
| Harrison, M | 1 |
| Murphy, R | 1 |
| Eiser, N | 1 |
| Angus, K | 1 |
| McHale, S | 1 |
| Anderson, W | 1 |
| ZuWallack, R | 1 |
| Broughton, J | 1 |
| Bailey, W | 1 |
| Wisniewski, M | 1 |
| Rickard, K | 2 |
| Udezue, E | 1 |
| D'Urzo, AD | 1 |
| De Salvo, MC | 1 |
| Ramirez-Rivera, A | 1 |
| Almeida, J | 1 |
| Sichletidis, L | 1 |
| Rapatz, G | 1 |
| Kottakis, J | 2 |
| Kunkel, G | 1 |
| Reilly, D | 1 |
| Church, N | 1 |
| Emmett, A | 1 |
| Knobil, K | 1 |
| Jarvis, B | 1 |
| Markham, A | 1 |
| Rennard, S | 1 |
| Gerber, RB | 1 |
| Kavuru, M | 1 |
| Hadcroft, J | 1 |
| Benhamou, D | 1 |
| Leclerc, V | 1 |
| Le Gros, V | 1 |
| Bourdeix, I | 1 |
| Basoglu, OK | 1 |
| Emre, S | 1 |
| Bacakoglu, F | 1 |
| Ates, H | 1 |
| Biring, MS | 1 |
| Madison, S | 1 |
| Mohsenifar, Z | 1 |
| Meier, R | 1 |
| Hall, GL | 1 |
| Sennhauser, FH | 1 |
| Wildhaber, JH | 1 |
| Chapman, KR | 1 |
| Mancini, G | 1 |
| Tellini, M | 1 |
| D'Ambrosio, R | 1 |
| Cornia, G | 1 |
| Sackner, MA | 1 |
| Schultze-Werninghaus, G | 1 |
| Gonsior, E | 1 |
| Meier-Sydow, J | 1 |
| Harken, AH | 1 |
| Pringle, JM | 1 |
| Badoux, S | 1 |
| Uffholtz, H | 1 |
| Sadoul, P | 1 |
| Lempereur, L | 1 |
| Sentissi, M | 1 |
| Whitsett, TL | 1 |
| Manion, CV | 1 |
| Kamat, SR | 2 |
| Hoskote, VR | 1 |
| Store, SD | 1 |
| Sanghavi, B | 1 |
| Sheth, UK | 1 |
| Kandus, J | 1 |
| Ruffin, RE | 1 |
| Ray, I | 1 |
| Evans, CJ | 1 |
| Vesco, R | 1 |
| Sussi, GW | 1 |
| Kreukniet, J | 1 |
| Ruggerini, R | 1 |
| Romitti, M | 1 |
| Sprocato, S | 1 |
| Bianco, F | 1 |
| Napiórkowska, W | 1 |
| Bromberg-Sznek, S | 1 |
| Vertun, B | 1 |
| Wolańska, A | 1 |
| Tylewska, S | 1 |
| Del Torre, L | 1 |
| Fiore, G | 1 |
| Macluso, S | 1 |
| Pesce, L | 1 |
| Melillo, G | 2 |
| Cocco, G | 1 |
| Vulterini, S | 1 |
| Bianco, MR | 1 |
| Pellicciotti, L | 1 |
| Sussi, G | 1 |
| Spina, G | 1 |
| Bonsignore, C | 1 |
| Zanotelli, F | 1 |
| Camerota, G | 1 |
| Pontiggia, P | 1 |
| Curti, PC | 1 |
| Giuliano, V | 1 |
| Martelli, GC | 1 |
| Verrua, D | 1 |
| Babolini, G | 1 |
| Gemelli, M | 1 |
| Capone, M | 2 |
| Coglitore, G | 1 |
| Ministeri, S | 1 |
| Pinizzotto, G | 1 |
| Barberio, G | 1 |
| Sorbini, CA | 3 |
| Todisco, T | 1 |
| Boschetti, E | 1 |
| Cesco, G | 1 |
| Fiora, L | 1 |
| Roberts, JA | 1 |
| Challenor, VF | 1 |
| Waller, DG | 1 |
| Hekking, PR | 2 |
| Brouwers, JW | 1 |
| Schermers, HP | 1 |
| Palmer, JB | 1 |
| Stuart, AM | 1 |
| Shepherd, GL | 1 |
| Viskum, K | 1 |
| Tan, WC | 2 |
| Chan, TB | 1 |
| Ang, SM | 1 |
| Wempe, JB | 1 |
| Breederveld, N | 1 |
| Kort, E | 1 |
| van der Mark, TW | 1 |
| Rutten-van Mölken, MP | 1 |
| van Doorslaer, EK | 1 |
| Molema, J | 1 |
| Akkermans, R | 1 |
| van Grunsven, PM | 1 |
| O'Driscoll, BR | 4 |
| Kay, EA | 2 |
| Taylor, RJ | 3 |
| Weatherby, H | 1 |
| Chetty, MC | 1 |
| Bernstein, A | 3 |
| Dickinson, ET | 1 |
| O'Connor, RE | 1 |
| Megargel, R | 1 |
| Banasiak, W | 1 |
| Telichowski, C | 1 |
| Molenda, W | 1 |
| Goldman, JM | 1 |
| Teale, C | 2 |
| Frans, A | 2 |
| Speelberg, B | 1 |
| Folgering, HT | 1 |
| Sterk, PJ | 2 |
| van Herwaarden, CL | 2 |
| Lándsér, FJ | 1 |
| Polko, AH | 2 |
| Visser, BF | 2 |
| Ruzkowski, CJ | 1 |
| Sanowski, RA | 1 |
| Austin, J | 1 |
| Rohwedder, JJ | 1 |
| Waring, JP | 1 |
| Dow, L | 1 |
| Coggon, D | 1 |
| Holgate, ST | 1 |
| Clerbaux, T | 1 |
| Henry, P | 1 |
| Veriter, C | 1 |
| Nullens, W | 1 |
| Detry, B | 1 |
| Cao, ML | 1 |
| Raphael, D | 1 |
| Aalto, E | 1 |
| Havu, M | 1 |
| Kotaniemi, J | 1 |
| Nieminen, P | 1 |
| Svahn, T | 1 |
| Svensson, M | 1 |
| Valta, R | 1 |
| Thomas, P | 1 |
| Pugsley, JA | 1 |
| Stewart, JH | 1 |
| Morrison, JF | 1 |
| Mohammed, AF | 1 |
| Anderson, K | 1 |
| Matusiewicz, SP | 1 |
| Greening, AP | 1 |
| Lai, CK | 1 |
| Legge, JS | 1 |
| Friend, JA | 1 |
| Braun, SR | 2 |
| Levy, SF | 1 |
| Stengel, PW | 1 |
| Williams, GD | 1 |
| Silbaugh, SA | 1 |
| Bel, EH | 1 |
| Zwinderman, AH | 1 |
| Timmers, MC | 1 |
| Dijkman, JH | 1 |
| Wong, D | 2 |
| Charpin, D | 1 |
| Maesen, F | 1 |
| Greefhorst, A | 1 |
| Prins, J | 1 |
| Tan, Y | 1 |
| Zweers, P | 1 |
| Graafsma, SJ | 1 |
| Visch, MB | 1 |
| Singer, J | 3 |
| Keller, J | 2 |
| Gay, PC | 1 |
| Patel, HG | 1 |
| Nelson, SB | 1 |
| Gilles, B | 1 |
| Hubmayr, RD | 1 |
| Fernandez, A | 1 |
| Lazaro, A | 1 |
| Garcia, A | 1 |
| Aragon, C | 1 |
| Cerda, E | 1 |
| Patrick, DM | 1 |
| Dales, RE | 1 |
| Stark, RM | 1 |
| Laliberte, G | 1 |
| Dickinson, G | 1 |
| Hoffarth, HP | 1 |
| Freyberger, H | 1 |
| Völkl, KP | 1 |
| Milroy, R | 1 |
| Carter, R | 1 |
| Carlyle, D | 1 |
| Kaspar, P | 1 |
| Härtl, W | 1 |
| Petro, W | 1 |
| Bruni, B | 1 |
| Dottorini, ML | 1 |
| Peccini, F | 1 |
| Motolese, M | 1 |
| Lecaillon, JB | 1 |
| Weir, DC | 1 |
| Burge, PS | 2 |
| Walshaw, M | 1 |
| Chapman, BJ | 1 |
| Crompton, GK | 1 |
| Vik-Mo, H | 1 |
| Halvorsen, FJ | 1 |
| Thorsen, E | 1 |
| Walde, NH | 1 |
| Rosland, GA | 1 |
| Eidelman, DH | 1 |
| Sami, MH | 1 |
| McGregor, M | 1 |
| Cosio, MG | 1 |
| Mols, P | 1 |
| Ham, H | 1 |
| Naeije, N | 1 |
| Dechamps, P | 1 |
| Huynh, CH | 1 |
| Vandenbosch, L | 1 |
| Vathenen, AS | 1 |
| Britton, JR | 1 |
| Cookson, JB | 1 |
| Wharrad, HJ | 1 |
| Tattersfield, AE | 1 |
| McKenzie, WN | 1 |
| Copeland, C | 1 |
| Knight, L | 1 |
| Ellersieck, M | 1 |
| Horsley, MG | 1 |
| Chambers, DK | 1 |
| Berry, RB | 1 |
| Shinto, RA | 1 |
| Wong, FH | 1 |
| Despars, JA | 1 |
| Wolkove, N | 2 |
| Dajczman, E | 1 |
| Colacone, A | 1 |
| Kreisman, H | 2 |
| Verschoof, AC | 1 |
| Assoufi, BK | 1 |
| Hodson, ME | 1 |
| Bossert, J | 1 |
| Träger, E | 1 |
| Bauer, K | 1 |
| Lorenz, PR | 1 |
| Seibel, K | 1 |
| Neiss, A | 1 |
| Eandi, M | 1 |
| Poukkula, A | 1 |
| Korhonen, UR | 1 |
| Huikuri, H | 1 |
| Linnaluoto, M | 1 |
| Townsend, M | 4 |
| Nogradi, S | 2 |
| Jodice, F | 1 |
| De Felice, A | 1 |
| Campisi, V | 1 |
| Di Filippo, A | 1 |
| Foddai, G | 1 |
| Franzone, JS | 1 |
| Grossi, E | 1 |
| Lette, J | 1 |
| Cerino, M | 1 |
| Laverdiere, M | 1 |
| Tremblay, J | 1 |
| Prenovault, J | 1 |
| Kraemer, R | 1 |
| Keller, JL | 3 |
| Whitehouse, AM | 1 |
| Novosel, S | 1 |
| Kubyshkin, VF | 1 |
| Soldatchenko, SS | 1 |
| Konovalov, VI | 1 |
| Germouty, J | 1 |
| Bründler, H | 1 |
| Godly, R | 1 |
| Herzog, H | 1 |
| Giosuè, S | 1 |
| Guerrini, P | 1 |
| Cafaggi, R | 1 |
| D'Onofrio, V | 1 |
| Perrone, N | 1 |
| Scano, M | 1 |
| Casali, L | 1 |
| Rossi, A | 1 |
| Manazza, P | 1 |
| Colombo, ML | 1 |
| Zoia, MC | 1 |
| Würtemberger, G | 1 |
| Weil, R | 1 |
| Schulte-Mönting, J | 1 |
| Matthys, H | 1 |
| Easton, PA | 2 |
| Jadue, C | 1 |
| Dhingra, S | 1 |
| Marangio, E | 1 |
| Pesci, A | 1 |
| Mori, A | 1 |
| Marchioni, M | 1 |
| Bertorelli, G | 1 |
| Aquilina, R | 1 |
| Bergero, F | 1 |
| Noceti, P | 1 |
| Mirabelli, S | 1 |
| Luciani, G | 1 |
| McIntosh, D | 1 |
| Capretti, A | 1 |
| Dantes, M | 1 |
| De Gasperi, R | 1 |
| D'Ambrosio, V | 1 |
| Connolly, CK | 1 |
| Chan, NS | 1 |
| Cochrane, GM | 1 |
| Crane, J | 3 |
| Gamble, S | 1 |
| Purdie, G | 1 |
| Lloberes, P | 1 |
| Ramis, L | 1 |
| Montserrat, JM | 1 |
| Serra, J | 1 |
| Campistol, J | 1 |
| Picado, C | 1 |
| Agusti-Vidal, A | 1 |
| Barnes, D | 1 |
| Delaney, JC | 1 |
| Pugsley, SO | 2 |
| Bennett, J | 1 |
| Osman, J | 1 |
| Blainey, AD | 1 |
| Davies, RJ | 1 |
| Swinburn, CR | 1 |
| Wakefield, JM | 1 |
| Newman, SP | 1 |
| Bell, D | 1 |
| Kirby, TP | 1 |
| Nicoll, JJ | 1 |
| Brash, HM | 1 |
| Connaughton, JJ | 1 |
| Muir, AL | 1 |
| Burgess, CD | 2 |
| Graham, AN | 2 |
| Maling, TJ | 2 |
| Chinn, DJ | 1 |
| Askew, J | 1 |
| Rowley, L | 1 |
| Cotes, JE | 1 |
| Papiris, S | 1 |
| Galavotti, V | 1 |
| Sturani, C | 1 |
| Bronsky, E | 1 |
| Bucholtz, GA | 1 |
| Busse, WW | 1 |
| Chervinsky, P | 1 |
| Condemi, J | 1 |
| Ghafouri, MA | 1 |
| Hudson, L | 1 |
| Lakshminarayan, S | 1 |
| Lockey, R | 1 |
| Reese, ME | 1 |
| Jenkins, SC | 1 |
| Heaton, RW | 1 |
| Fulton, TJ | 1 |
| Short, HD | 1 |
| Taylor, DW | 1 |
| Bigi, R | 1 |
| Camerone, G | 1 |
| Corradetti, C | 1 |
| Durante, V | 1 |
| Occhi, G | 1 |
| Toloni, V | 1 |
| Gove, RI | 1 |
| Shepherd, J | 1 |
| Lindsjö, M | 1 |
| Boman, G | 1 |
| Lindström, B | 1 |
| Strandberg, K | 1 |
| Wiholm, BE | 1 |
| Wolstenholme, RJ | 1 |
| Shettar, SP | 1 |
| Taher, F | 1 |
| Hatton, B | 1 |
| Olivenstein, R | 1 |
| Cohen, C | 1 |
| Frank, H | 1 |
| Valcarenghi, G | 1 |
| Druz, WS | 1 |
| Starkey, PW | 1 |
| Yu, C | 1 |
| Shaughnessy, TK | 1 |
| Rolla, G | 1 |
| Arossa, W | 1 |
| Bucca, C | 1 |
| Bugiani, M | 1 |
| Patel, MH | 1 |
| Kolhatkar, VP | 1 |
| Mahashur, AA | 1 |
| Perri, G | 1 |
| Giovannini, M | 1 |
| Spada, E | 1 |
| Taylor, SM | 1 |
| Paré, PD | 1 |
| Armour, CL | 1 |
| Hogg, JC | 1 |
| Schellenberg, RR | 1 |
| Myhre, KI | 1 |
| Arnulf, V | 1 |
| Walstad, RA | 1 |
| Verdecchia, P | 1 |
| Cornelli, U | 1 |
| Imberger, H | 1 |
| Buick, B | 1 |
| Kinney, C | 1 |
| Lowry, RC | 1 |
| McDevitt, DG | 1 |
| Gugger, M | 1 |
| Crivelli, AM | 1 |
| Galeazzi, RL | 1 |
| Bachofen, H | 1 |
| Filuk, RB | 1 |
| Lim, TK | 1 |
| Haasis, R | 1 |
| Jeschke, D | 1 |
| Schick, HD | 1 |
| Hilpert, P | 1 |
| Kersten, W | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| A Randomized Trial Comparing Metered Dose Inhalers and Breath Actuated Nebulizers[NCT02777125] | 980 participants (Actual) | Interventional | 2014-10-31 | Completed | |||
| Diagnostic Accuracy Of Forced Oscillation Technique To Detect Lung Function Anomalies[NCT04006964] | 579 participants (Actual) | Observational | 2018-10-18 | Completed | |||
| Efficacy of an Education Protocol in the Correction of Inhalation Techniques in Patients With Chronic Obstructive Pulmonary Disease[NCT03144557] | 61 participants (Actual) | Interventional | 2017-01-02 | Completed | |||
| Effects of Expiratory Positive Airway Pressure on Dyspnea and Exercise Tolerance in Patients With Chronic Obstructive Pulmonary Disease[NCT02566915] | 19 participants (Anticipated) | Interventional | 2015-08-31 | Enrolling by invitation | |||
| Individualized Dosing Schedule of Inhaled Bronchodilator for Endotracheally Intubated Chronic Obstructive Pulmonary Disease Patients[NCT01933984] | 51 participants (Actual) | Interventional | 2013-08-31 | Completed | |||
| Pulmonary Gas Exchange Response to Indacaterol in Stable Symptomatic Chronic Obstructive Pulmonary Disease Patients[NCT02547558] | Phase 4 | 20 participants (Anticipated) | Interventional | 2015-10-31 | Not yet recruiting | ||
| A 12-week, Double-blind, Multicenter, 3-crossover, Placebo Controlled and Randomized Trial to Investigate the Efficacy and Safety of 10mg and 5mg Bambuterol Tablets Once Daily in Patients With Chronic Obstructive Pulmonary Disease (COPD)[NCT01796730] | Phase 4 | 60 participants (Actual) | Interventional | 2013-02-28 | Completed | ||
| Impact of Negative Pressure Ventilation in Patients Hospitalized With Acute Hypercapnic Respiratory Failure[NCT06108284] | 50 participants (Anticipated) | Interventional | 2023-11-30 | Not yet recruiting | |||
| Change of Inspiratory Peak Flow After Bronchial Dilatation on Patients With Moderate to Severe COPD[NCT00561886] | Phase 4 | 40 participants (Actual) | Interventional | 2007-04-30 | Completed | ||
| The RETORNUS Study: Dual Training to Restore the Function of Respiratory Muscles in Stroke Patients[NCT02125760] | 129 participants (Actual) | Interventional | 2011-03-31 | Completed | |||
| The Cardiopulmonary Effect of Inhaled Beta-2-agonists on Adult Ventrucular Septal Defect Patients With Persistant or Surgically Corrected Conditions - The VENTI Trial[NCT02914652] | Phase 4 | 96 participants (Actual) | Interventional | 2016-10-15 | Completed | ||
| Validation of the Risk Stratification Score in Idiopathic Pulmonary Fibrosis[NCT02632123] | 260 participants (Anticipated) | Observational | 2015-12-31 | Recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
Patient disposition is measured as subjects requiring further treatment and being admitted to hospital. We record the number of patients in each cohort that required admission to the hospital after being evaluated and treated in the Emergency Department. (NCT02777125)
Timeframe: 6 hours
| Intervention | Participants admitted to the Hospital (Number) |
|---|---|
| Albuterol by Metered Dose Inhaler | 53 |
| Albuterol Breath Actuated Nebulizer | 57 |
Defined as a repeat visit to the Emergency Department for a complaint related to their wheezing, within 7 days of initial enrollment in the study. (NCT02777125)
Timeframe: Within 7 days of initial presentation
| Intervention | Participants (Count of Participants) |
|---|---|
| Albuterol by Metered Dose Inhaler | 5 |
| Albuterol Breath Actuated Nebulizer | 4 |
Defined as a patient needing ondansetron for symptomatic relief of their nausea after initiating therapy in the Emergency Department. (NCT02777125)
Timeframe: 6 hours
| Intervention | Participants (Count of Participants) |
|---|---|
| Albuterol by Metered Dose Inhaler | 14 |
| Albuterol Breath Actuated Nebulizer | 18 |
Defined as anytime after initiation of therapy when the patient's heart rate exceeded age adjusted normal sinus rhythm heart rates for their age. Not uncommonly, patient's experience tachycardia as an unintended side effect of receiving albuterol. Tachycardia can result in a patient requiring further observation in the Emergency department and therefore increasing Emergency Department length of stay. We want to determine if indeed tachycardia is unavoidable, or if its presence suggests that patients are receiving too much albuterol or if albuterol is being given by the wrong appliance. (NCT02777125)
Timeframe: 6 hours
| Intervention | Participants (Count of Participants) |
|---|---|
| Albuterol by Metered Dose Inhaler | 101 |
| Albuterol Breath Actuated Nebulizer | 141 |
Emergency department length of stay is defined as the point of time when the patient checked into the Emergency Department to the time of final disposition. (NCT02777125)
Timeframe: 6 hours
| Intervention | minutes (Mean) | |
|---|---|---|
| Mild severity | Moderate severity | |
| Albuterol Breath Actuated Nebulizer | 197 | 245 |
| Albuterol by Metered Dose Inhaler | 192 | 232 |
The value can be expressed as relative deviation from target =(measured Raw - target Raw)/target Raw X100 (NCT01933984)
Timeframe: Airway resistance will be recorded everyday. If a patient's ventilator was liberated less than 28 days, the day of liberation was the reported time frame. If the day of ventilator liberation was over 28 days, the 28th day was the reported time frame.
| Intervention | percentage of relative Raw deviation (Mean) |
|---|---|
| Individualized Dosing | 9 |
| Fixed Dosing | 44 |
The percentage of participants died at day 180. (NCT01933984)
Timeframe: the 180th day after enrollment
| Intervention | percentage of participants (Number) |
|---|---|
| Individualized Dosing | 35 |
| Fixed Dosing | 40 |
The number of episodes of nosocomial pneumonia happened by day 28. And nosocomial pneumonia is a lower respiratory infection that was not incubating at the time of hospital admission and that presents clinically 2 or more days after hospitalization. (NCT01933984)
Timeframe: the 28th day after enrollment
| Intervention | episodes of nosocomial pneumonia (Median) |
|---|---|
| Individualized Dosing | 0 |
| Fixed Dosing | 0 |
The number of total puff of rescue short-acting bronchodilator. (NCT01933984)
Timeframe: the 28th day after enrollment
| Intervention | puffs (Number) |
|---|---|
| Individualized Dosing | 0 |
| Fixed Dosing | 0 |
The numbers of episode of drug-related adverse effect. Naranjo score should be over 4 to be considered drug-related adverse effect. Naranjo score range form 0 to 9, and the higher scores means a higher relationship with drug-related adverse effect. (NCT01933984)
Timeframe: From day 1 to day 28 after enrollment
| Intervention | episodes (Median) |
|---|---|
| Individualized Dosing | 0 |
| Fixed Dosing | 0 |
The deviation of ∆Raw from the personal target, which was calculated as (measured Raw-target Raw)/target Raw multiplied by 100. (NCT01933984)
Timeframe: Airway resistance will be recorded everyday. If a patient's ventilator was liberated less than 28 days, the day of liberation was the reported time frame. If the day of ventilator liberation was over 28 days, the 28th day was the reported time frame.
| Intervention | percentage of relative Raw deviation (Mean) |
|---|---|
| Individualized Dosing | -3 |
| Fixed Dosing | 0.4 |
The number of participants who breath without ventilator by day 28 (NCT01933984)
Timeframe: the 28th day after enrollment
| Intervention | the number of participants (Number) |
|---|---|
| Individualized Dosing | 19 |
| Fixed Dosing | 22 |
Ventilator-free days from day 1 to 28 after enrollment (NCT01933984)
Timeframe: From day 1 to day 28 after enrollment
| Intervention | day (Number) |
|---|---|
| Individualized Dosing | 19 |
| Fixed Dosing | 22 |
19 reviews available for albuterol and Obstructive Lung Diseases
| Article | Year |
|---|---|
Long-acting beta2-agonists for chronic obstructive pulmonary disease patients with poorly reversible airflow limitation.
Topics: Adrenergic beta-Agonists; Albuterol; Ethanolamines; Humans; Lung Diseases, Obstructive; Randomized C | 2002 |
Short-acting beta 2 agonists for stable chronic obstructive pulmonary disease.
Topics: Administration, Inhalation; Adrenergic beta-Agonists; Adult; Albuterol; Bronchodilator Agents; Human | 2002 |
Long-acting beta2-agonists for poorly reversible chronic obstructive pulmonary disease.
Topics: Adrenergic beta-Agonists; Albuterol; Bronchodilator Agents; Ethanolamines; Formoterol Fumarate; Huma | 2006 |
[Bronchodilator treatment of COPD].
Topics: Adrenal Cortex Hormones; Adrenergic beta-Agonists; Albuterol; Bronchodilator Agents; Clinical Trials | 1998 |
[Inhaler therapy for adults with obstructive lung diseases: powder or aerosol?].
Topics: Administration, Inhalation; Adult; Aerosols; Albuterol; Asthma; Bronchodilator Agents; Female; Human | 1998 |
[Use of delayed-action beta-2 mimetics in the management of chronic obstructive bronchial diseases--for].
Topics: Adrenergic beta-Agonists; Albuterol; Bronchodilator Agents; Delayed-Action Preparations; Humans; Lun | 1999 |
Prospects for improved therapy in chronic obstructive pulmonary disease by the use of levalbuterol.
Topics: Adrenergic beta-Agonists; Albuterol; Asthma; Bronchodilator Agents; Humans; Inflammation; Lung Disea | 1999 |
Are anticholinergics first choice bronchodilators in the treatment of stable chronic obstructive pulmonary disease?
Topics: Albuterol; Bronchodilator Agents; Cholinergic Antagonists; Humans; Lung Diseases, Obstructive; Respi | 1999 |
Anticholinergic bronchodilators.
Topics: Adrenergic beta-Agonists; Albuterol; Bronchodilator Agents; Cholinergic Antagonists; Drug Combinatio | 1999 |
Bronchodilator therapy in chronic obstructive pulmonary disease.
Topics: Adrenergic beta-Agonists; Albuterol; Bronchodilator Agents; Cholinergic Antagonists; Drug Therapy, C | 2000 |
Long-acting beta2-agonists for chronic obstructive pulmonary disease.
Topics: Adrenergic beta-Agonists; Albuterol; Ethanolamines; Formoterol Fumarate; Humans; Lung Diseases, Obst | 2000 |
Short-acting beta 2 agonists for stable chronic obstructive pulmonary disease.
Topics: Administration, Inhalation; Adrenergic beta-Agonists; Adult; Albuterol; Bronchodilator Agents; Human | 2000 |
Short-acting beta 2 agonists for stable COPD.
Topics: Administration, Inhalation; Adrenergic beta-Agonists; Adult; Albuterol; Bronchodilator Agents; Human | 2000 |
Bronchodilators in cystic fibrosis.
Topics: Adolescent; Adult; Albuterol; Bronchodilator Agents; Child, Preschool; Chronic Disease; Clinical Tri | 2000 |
Clinical aspects of inhaled anticholinergic therapy.
Topics: Administration, Inhalation; Albuterol; Bronchoconstriction; Bronchodilator Agents; Cholinergic Antag | 2000 |
Inhaled salmeterol: a review of its efficacy in chronic obstructive pulmonary disease.
Topics: Administration, Inhalation; Adrenergic beta-Agonists; Albuterol; Bronchodilator Agents; Cardiovascul | 2001 |
Alternative mechanisms for long-acting beta(2)-adrenergic agonists in COPD.
Topics: Adrenergic beta-Agonists; Albuterol; Bronchodilator Agents; Ethanolamines; Formoterol Fumarate; Huma | 2001 |
Seretide for obstructive lung disease.
Topics: Administration, Inhalation; Albuterol; Androstadienes; Anti-Inflammatory Agents; Clinical Trials as | 2002 |
Theophylline as a bronchodilator in COPD and its combination with inhaled beta-adrenergic drugs.
Topics: Adrenergic beta-Agonists; Albuterol; Animals; Asthma; Bronchi; Bronchitis; Clinical Trials as Topic; | 1987 |
207 trials available for albuterol and Obstructive Lung Diseases
| Article | Year |
|---|---|
A Controlled Trial of Inhaled Bronchodilators in Familial Dysautonomia.
Topics: Administration, Inhalation; Adolescent; Adrenergic beta-2 Receptor Agonists; Adult; Airway Resistanc | 2018 |
Efficacy of Inhaled Levalbuterol Compared to Albuterol in Horses with Recurrent Airway Obstruction.
Topics: Albuterol; Animals; Bronchodilator Agents; Cross-Over Studies; Female; Horse Diseases; Horses; Leval | 2016 |
Fluctuation analysis of lung function as a predictor of long-term response to beta2-agonists.
Topics: Adrenergic beta-Agonists; Adult; Albuterol; Female; Genotype; Humans; Lung; Lung Diseases, Obstructi | 2009 |
Repeat dosing of albuterol via metered-dose inhaler in infants with acute obstructive airway disease: a randomized controlled safety trial.
Topics: Administration, Inhalation; Aerosols; Albuterol; Bronchodilator Agents; Dose-Response Relationship, | 2010 |
A prospective, comparative trial of standard and breath-actuated nebulizer: efficacy, safety, and satisfaction.
Topics: Administration, Inhalation; Aged; Albuterol; Bronchodilator Agents; Cross-Over Studies; Female; Hear | 2012 |
Effect of aerosolized albuterol sulfate on resting energy expenditure determined by use of open-flow indirect calorimetry in horses with recurrent airway obstruction.
Topics: Aerosols; Albuterol; Animals; Basal Metabolism; Calorimetry, Indirect; Horse Diseases; Horses; Hypno | 2003 |
beta(2)-Agonist delivery via a resuscitator bag (Ambu MediBag): a comparison with a metered-dose inhaler using the Volumatic-Spacer.
Topics: Acute Disease; Administration, Inhalation; Adrenergic beta-Agonists; Airway Resistance; Albuterol; B | 2004 |
Effects of prednisolone in chronic airflow limitation.
Topics: Adult; Aged; Albuterol; Clinical Trials as Topic; Double-Blind Method; Female; Forced Expiratory Vol | 1984 |
Effect of oral prednisolone on response to salbutamol and ipratropium bromide aerosols in patients with chronic airflow obstruction.
Topics: Aerosols; Aged; Albuterol; Atropine Derivatives; Clinical Trials as Topic; Drug Resistance; Drug Syn | 1983 |
Assessment of the clinical usefulness of nebulised ipratropium bromide in patients with chronic airflow limitation.
Topics: Aerosols; Aged; Albuterol; Atropine Derivatives; Clinical Trials as Topic; Double-Blind Method; Drug | 1984 |
A comparison of effects of inhaling a combined preparation of fenoterol with ipratropium bromide (Duovent) with those of fenoterol and salbutamol.
Topics: Adult; Aerosols; Aged; Albuterol; Atropine Derivatives; Blood Pressure; Drug Combinations; Ethanolam | 1984 |
[Use of a salbutamol-beclomethasone dipropionate combination in the treatment of chronic obstructive bronchopneumopathy].
Topics: Albuterol; Beclomethasone; Clinical Trials as Topic; Drug Therapy, Combination; Humans; Lung Disease | 1984 |
Breathlessness and exercise tolerance in chronic airflow obstruction: 2-hourly versus 4-hourly salbutamol by inhalation.
Topics: Aged; Albuterol; Clinical Trials as Topic; Humans; Lung Diseases, Obstructive; Middle Aged; Physical | 1983 |
Inhaled powder and aerosol salbutamol in metacholine-induced bronchial obstruction.
Topics: Administration, Intranasal; Aerosols; Albuterol; Clinical Trials as Topic; Humans; Lung Diseases, Ob | 1983 |
Clenbuterol and salbutamol in the symptomatic treatment of patients with reversible airways obstruction.
Topics: Adolescent; Adult; Aged; Albuterol; Clenbuterol; Clinical Trials as Topic; Drug Administration Sched | 1983 |
Comparative study of the effects of intravenous administration of aminophylline, salbutamol and terbutaline in patients suffering from reversible airways obstruction.
Topics: Adult; Albuterol; Aminophylline; Bronchial Spasm; Clinical Trials as Topic; Double-Blind Method; Fem | 1984 |
Comparative study of the bronchospasmolytic effect of fenoterol (0.2 mg) salbutamol (0.4 mg) as powder inhalations in 20 patients with reversible bronchial obstruction.
Topics: Administration, Intranasal; Adult; Airway Resistance; Albuterol; Asthma; Clinical Trials as Topic; D | 1984 |
Protective effect of various drugs in preventing an acetylcholine-induced bronchoconstriction.
Topics: Acetylcholine; Adult; Aged; Airway Resistance; Albuterol; Allergens; Clinical Trials as Topic; Ethyl | 1980 |
Comparison of ipratropium bromide and salbutamol by aerosolized solution.
Topics: Aerosols; Aged; Albuterol; Atropine Derivatives; Clinical Trials as Topic; Double-Blind Method; Huma | 1981 |
Comparison of wet and dry aerosol salbutamol.
Topics: Aerosols; Albuterol; Dose-Response Relationship, Drug; Double-Blind Method; Hemodynamics; Humans; Lu | 1983 |
Pressurized aerosol inhaler technique: how important are inhalation from residual volume, inspiratory flow rate and the time interval between puffs?
Topics: Adolescent; Adult; Aerosols; Aged; Albuterol; Female; Humans; Isoproterenol; Lung Diseases, Obstruct | 1983 |
Bronchodilator response to oral aminophylline and terbutaline versus aerosol albuterol in patients with chronic obstructive pulmonary disease.
Topics: Aerosols; Aged; Albuterol; Aminophylline; Double-Blind Method; Drug Therapy, Combination; Female; Fo | 1983 |
Experiences with large doses of beta 2-agonists inhaled from nebulizers.
Topics: Aerosols; Albuterol; Drug Administration Schedule; Humans; Lung Diseases, Obstructive; Prospective S | 1983 |
[Double-blind crossover study on the long-term effects of aminophylline retard tablets on the use of salbutamol aerosol spray].
Topics: Aerosols; Albuterol; Aminophylline; Clinical Trials as Topic; Delayed-Action Preparations; Double-Bl | 1982 |
Dose-response study of inhaled salbutamol powder in chronic airflow obstruction.
Topics: Aged; Albuterol; Dose-Response Relationship, Drug; Double-Blind Method; Humans; Lung Diseases, Obstr | 1983 |
Domiciliary nebulised salbutamol solution in severe chronic airway obstruction.
Topics: Aerosols; Aged; Albuterol; Clinical Trials as Topic; Double-Blind Method; Female; Humans; Lung Disea | 1980 |
Maintenance of bronchodilation in chronic reversible airways obstruction. Comparison between choline theophyllinate and salbutamol.
Topics: Adult; Albuterol; Choline; Clinical Trials as Topic; Female; Forced Expiratory Flow Rates; Humans; L | 1982 |
Combination of aminophylline (Phyllocontin Continus tablets) and salbutamol in the management of chronic obstructive airways disease.
Topics: Adult; Aged; Albuterol; Aminophylline; Delayed-Action Preparations; Drug Therapy, Combination; Femal | 1980 |
Inhaled formoterol dry powder in the treatment of patients with reversible obstructive airway disease. A 3-month, placebo-controlled comparison of the efficacy and safety of formoterol and salbutamol, followed by a 12-month trial with formoterol.
Topics: Administration, Inhalation; Adolescent; Adrenergic beta-Agonists; Adult; Aged; Albuterol; Bronchodil | 1995 |
Arrhythmogenic effects of combined orally administered theophylline and albuterol in patients with chronic obstructive pulmonary disease.
Topics: Administration, Oral; Aged; Albuterol; Arrhythmias, Cardiac; Bronchodilator Agents; Drug Therapy, Co | 1994 |
Efficacy of inhaled salmeterol in the management of smokers with chronic obstructive pulmonary disease: a single centre randomised, double blind, placebo controlled, crossover study.
Topics: Adult; Aged; Albuterol; Bronchodilator Agents; Cross-Over Studies; Double-Blind Method; Female; Huma | 1995 |
Comparison of nebulised salbutamol and ipratropium bromide with salbutamol alone in the treatment of chronic obstructive pulmonary disease.
Topics: Administration, Inhalation; Aged; Albuterol; Drug Combinations; Forced Expiratory Volume; Humans; Ip | 1995 |
Terbutaline vs albuterol for out-of-hospital respiratory distress: randomized, double-blind trial.
Topics: Administration, Inhalation; Adult; Aged; Albuterol; Bronchodilator Agents; Double-Blind Method; Dysp | 1995 |
Salmeterol and formoterol in partially reversible severe chronic obstructive pulmonary disease: a dose-response study.
Topics: Adrenergic beta-Agonists; Aged; Albuterol; Bronchodilator Agents; Cross-Over Studies; Dose-Response | 1995 |
Effects of the mixed phosphodiesterase III/IV inhibitor, zardaverine, on airway function in patients with chronic airflow obstruction.
Topics: Aged; Albuterol; Bronchodilator Agents; Double-Blind Method; Forced Expiratory Volume; Humans; Lung | 1995 |
Is an anticholinergic agent superior to a beta 2-agonist in improving dyspnea and exercise limitation in COPD?
Topics: Administration, Inhalation; Adrenergic beta-2 Receptor Agonists; Adrenergic beta-Agonists; Aged; Alb | 1995 |
Effects of combined treatment with glycopyrrolate and albuterol in acute exacerbation of chronic obstructive pulmonary disease.
Topics: Acute Disease; Administration, Inhalation; Aerosols; Aged; Albuterol; Double-Blind Method; Drug Ther | 1995 |
The combination of ipratropium and albuterol is more effective than either agent alone.
Topics: Albuterol; Drug Combinations; Female; Forced Expiratory Volume; Humans; Ipratropium; Lung Diseases, | 1995 |
Salbutamol powder inhaled from the Diskhaler compared to salbutamol as nebulizer solution in severe chronic airways obstruction.
Topics: Administration, Inhalation; Aged; Aged, 80 and over; Albuterol; Cross-Over Studies; Double-Blind Met | 1995 |
The influence of an inhaled steroid on quality of life in patients with asthma or COPD.
Topics: Administration, Inhalation; Albuterol; Asthma; Beclomethasone; Female; Forced Expiratory Volume; Hea | 1995 |
Efficacy and tolerance of a 12-week treatment with inhaled formoterol in patients with reversible obstructive lung disease.
Topics: Administration, Inhalation; Adrenergic beta-Agonists; Adult; Aged; Albuterol; Double-Blind Method; E | 1994 |
Effect of oral theophylline on resting energy expenditure in normal volunteers.
Topics: Adult; Albuterol; Carbon Dioxide; Double-Blind Method; Drug Interactions; Energy Metabolism; Female; | 1994 |
Effects of beta 2-agonists during cardiopulmonary exercise test in COPD patients.
Topics: Adolescent; Adrenergic beta-Agonists; Adult; Aged; Albuterol; Bronchodilator Agents; Cross-Over Stud | 1994 |
Bronchodilating effects of combined therapy with clinical dosages of ipratropium bromide and salbutamol for stable COPD: comparison with ipratropium bromide alone.
Topics: Aged; Albuterol; Double-Blind Method; Drug Therapy, Combination; Forced Expiratory Volume; Humans; I | 1995 |
The additive effect of theophylline on a high-dose combination of inhaled salbutamol and ipratropium bromide in stable COPD.
Topics: Administration, Inhalation; Aged; Albuterol; Bronchi; Cross-Over Studies; Double-Blind Method; Drug | 1995 |
Effect of salmeterol and formoterol in patients with chronic obstructive pulmonary disease.
Topics: Administration, Inhalation; Adrenergic beta-Agonists; Aged; Aged, 80 and over; Albuterol; Bronchodil | 1994 |
Air trapping and cardiopulmonary exercise testing in patients with mild to moderate bronchial obstruction: clinical role of trapped gas measurements.
Topics: Adult; Aged; Albuterol; Double-Blind Method; Exercise Test; Female; Humans; Lung Diseases, Obstructi | 1994 |
Effect of high-dose salbutamol on cardiac rhythm in severe chronic airflow obstruction: a controlled study.
Topics: Aged; Albuterol; Arrhythmias, Cardiac; Carbon Dioxide; Electrocardiography, Ambulatory; Female; Forc | 1994 |
The use of two inhaled beta agonists for the treatment of COPD: a summary of European data.
Topics: Administration, Inhalation; Adrenergic beta-Agonists; Albuterol; Ethanolamines; Europe; Humans; Lung | 1993 |
The effect of increasing doses of beta-agonists on airflow in patients with chronic airflow limitation.
Topics: Administration, Inhalation; Adrenergic beta-Agonists; Aged; Aged, 80 and over; Albuterol; Double-Bli | 1993 |
The effect of controlled-release salbutamol on sleep and nocturnal oxygenation in patients with asthma and chronic obstructive pulmonary disease.
Topics: Albuterol; Asthma; Delayed-Action Preparations; Double-Blind Method; Female; Forced Expiratory Volum | 1994 |
Variability of bronchodilator response and effects of inhaled corticosteroid treatment in obstructive airways disease. Dutch CNSLD Study Group.
Topics: Administration, Inhalation; Adolescent; Adult; Albuterol; Asthma; Beclomethasone; Bronchi; Bronchial | 1993 |
A comparison of inhaled ipratropium, oral theophylline plus inhaled beta-agonist, and the combination of all three in patients with COPD.
Topics: Administration, Inhalation; Administration, Oral; Adult; Aged; Albuterol; Double-Blind Method; Drug | 1994 |
In chronic obstructive pulmonary disease, a combination of ipratropium and albuterol is more effective than either agent alone. An 85-day multicenter trial. COMBIVENT Inhalation Aerosol Study Group.
Topics: Administration, Inhalation; Adult; Aged; Aged, 80 and over; Albuterol; Double-Blind Method; Drug Com | 1994 |
Bronchodilator response to nebulized salbutamol in elderly patients with stable chronic airflow limitation.
Topics: Aerosols; Aged; Albuterol; Bronchi; Double-Blind Method; Female; Forced Expiratory Volume; Humans; L | 1993 |
Is oral theophylline effective in combination with both inhaled anticholinergic agent and inhaled beta 2-agonist in the treatment of stable COPD?
Topics: Administration, Oral; Aerosols; Aged; Albuterol; Delayed-Action Preparations; Double-Blind Method; D | 1993 |
Comparison of bronchodilator effects of fenoterol/ipratropium bromide and salbutamol in patients with chronic obstructive lung disease.
Topics: Aerosols; Aged; Albuterol; Bronchodilator Agents; Double-Blind Method; Drug Combinations; Female; Fe | 1993 |
Double-blind crossover study of nedocromil sodium in partially reversible chronic obstructive airways disease.
Topics: Adult; Aged; Aged, 80 and over; Albuterol; Anti-Inflammatory Agents, Non-Steroidal; Beclomethasone; | 1993 |
Eformoterol versus salbutamol in elderly patients with ROAD.
Topics: Adrenergic beta-Agonists; Aged; Aged, 80 and over; Albuterol; Bronchodilator Agents; Double-Blind Me | 1995 |
Eformoterol versus salbutamol in patients with ROAD.
Topics: Adolescent; Adrenergic beta-Agonists; Adult; Aged; Albuterol; Bronchodilator Agents; Double-Blind Me | 1995 |
[Effect duration and treatment effectiveness of salmeterol, fenoterol and salbutamol in severe forms of respiratory tract obstruction].
Topics: Adult; Aged; Aged, 80 and over; Airway Resistance; Albuterol; Bronchodilator Agents; Female; Fenoter | 1995 |
[Responder and non-responder in the bronchodilator test?].
Topics: Administration, Inhalation; Adrenergic beta-Agonists; Adult; Aged; Aged, 80 and over; Airway Resista | 1995 |
Nebulized bronchodilators for outpatient management of stable chronic obstructive pulmonary disease.
Topics: Administration, Inhalation; Adrenergic beta-Agonists; Aged; Albuterol; Ambulatory Care; Bronchodilat | 1996 |
Addition of anticholinergic solution prolongs bronchodilator effect of beta 2 agonists in patients with chronic obstructive pulmonary disease.
Topics: Administration, Intranasal; Adrenergic beta-Agonists; Aged; Albuterol; Bronchodilator Agents; Double | 1996 |
Inhaled bronchodilators reduce dynamic hyperinflation during exercise in patients with chronic obstructive pulmonary disease.
Topics: Administration, Inhalation; Adrenergic beta-Agonists; Aged; Albuterol; Bronchodilator Agents; Dyspne | 1996 |
[The effect of salmeterol in the treatment of smokers with chronic obstructive lung disease].
Topics: Adrenergic beta-Agonists; Adult; Albuterol; Bronchodilator Agents; Cross-Over Studies; Double-Blind | 1996 |
Sleep quality and nocturnal respiratory function with once-daily theophylline (Uniphyl) and inhaled salbutamol in patients with COPD.
Topics: Adrenergic beta-Agonists; Albuterol; Bronchodilator Agents; Cross-Over Studies; Double-Blind Method; | 1996 |
A comparison of the bronchodilating effects of salmeterol, salbutamol and ipratropium bromide in patients with chronic obstructive pulmonary disease.
Topics: Administration, Inhalation; Adrenergic beta-Agonists; Aged; Albuterol; Analysis of Variance; Cross-O | 1995 |
Effect of beta 2-adrenoceptor agonists on plasma potassium and cardiopulmonary responses on exercise in patients with chronic obstructive pulmonary disease.
Topics: Adrenergic beta-Agonists; Aged; Albuterol; Analysis of Variance; Cross-Over Studies; Double-Blind Me | 1996 |
Is driving oxygen flow rate clinically important for nebulizer therapy in patients with COPD?
Topics: Aged; Albuterol; Blood Flow Velocity; Cross-Over Studies; Female; Heart Rate; Humans; Lung Diseases, | 1995 |
A combination with clinical recommended dosages of salmeterol and ipratropium is not more effective than salmeterol alone in patients with chronic obstructive pulmonary disease.
Topics: Adrenergic beta-Agonists; Adult; Albuterol; Bronchodilator Agents; Cross-Over Studies; Drug Therapy, | 1996 |
Effects of regular salmeterol on lung function and exercise capacity in patients with chronic obstructive airways disease.
Topics: Albuterol; Bronchodilator Agents; Cross-Over Studies; Double-Blind Method; Exercise; Exercise Test; | 1996 |
Effects of bronchomotor tone and gas density on time dependence of forced expiratory vital capacity maneuver.
Topics: Adult; Aged; Albuterol; Asthma; Bronchodilator Agents; Female; Helium; Humans; Lung Diseases, Obstru | 1996 |
[Formoterol as inhalation powder in the treatment of patients with reversible obstructive lung diseases. A 3-month placebo-controlled comparison of the effects of formoterol and salbutamol, followed by a 12-month period with formoterol alone].
Topics: Administration, Inhalation; Adolescent; Adrenergic beta-Agonists; Adult; Aged; Albuterol; Bronchodil | 1996 |
Thermogenic effect of bronchodilators in patients with chronic obstructive pulmonary disease.
Topics: Aged; Albuterol; Bronchodilator Agents; Calorimetry, Indirect; Double-Blind Method; Energy Metabolis | 1997 |
Effects of nebulized beta 2-adrenergic agonists on pulmonary mechanics in anesthetized patients with chronic obstructive pulmonary disease.
Topics: Administration, Intranasal; Adrenergic beta-Agonists; Aged; Albuterol; Humans; Lung Diseases, Obstru | 1996 |
Oral doxophylline in patients with chronic obstructive pulmonary disease.
Topics: Administration, Oral; Adrenergic beta-Agonists; Adult; Aged; Albuterol; Antitussive Agents; Blood Ga | 1997 |
Effect of different albuterol dosing regimens in the treatment of acute exacerbation of chronic obstructive pulmonary disease.
Topics: Aerosols; Aged; Airway Obstruction; Albuterol; Bronchodilator Agents; Female; Forced Expiratory Volu | 1997 |
Quality of life changes in COPD patients treated with salmeterol.
Topics: Administration, Inhalation; Adrenergic beta-Agonists; Albuterol; Bronchodilator Agents; Cohort Studi | 1997 |
An evaluation of salmeterol in the treatment of chronic obstructive pulmonary disease (COPD)
Topics: Adult; Aged; Albuterol; Bronchodilator Agents; Dose-Response Relationship, Drug; Double-Blind Method | 1997 |
Salmeterol reduces dyspnea and improves lung function in patients with COPD.
Topics: Administration, Inhalation; Adrenergic beta-Agonists; Aged; Albuterol; Bronchodilator Agents; Cross- | 1997 |
Nebulized wet aerosol treatment in emergency department--is it essential? Comparison with large spacer device for metered-dose inhaler.
Topics: Aerosols; Aged; Albuterol; Asthma; Bronchodilator Agents; Chi-Square Distribution; Double-Blind Meth | 1997 |
Routine nebulized ipratropium and albuterol together are better than either alone in COPD. The COMBIVENT Inhalation Solution Study Group.
Topics: Adult; Aged; Aged, 80 and over; Albuterol; Analysis of Variance; Bronchodilator Agents; Drug Therapy | 1997 |
[The effect of selective agonist beta-adrenergic receptors on lung ventilation function in patients with chronic obstructive pulmonary disease].
Topics: Administration, Inhalation; Adrenergic beta-Agonists; Adult; Aged; Albuterol; Female; Humans; Lung; | 1998 |
The effect of oral corticosteroids on bronchodilator responses in COPD.
Topics: Aged; Aged, 80 and over; Albuterol; Bronchodilator Agents; Cross-Over Studies; Dose-Response Relatio | 1998 |
A comparison of bronchodilating effects of salmeterol and oxitropium bromide in stable chronic obstructive pulmonary disease.
Topics: Aged; Albuterol; Area Under Curve; Bronchodilator Agents; Cross-Over Studies; Dose-Response Relation | 1998 |
Comparison of efficacy and ease of handling of salmeterol and terbutaline powder inhalers.
Topics: Adolescent; Adrenergic beta-Agonists; Adult; Aged; Albuterol; Female; Forced Expiratory Volume; Huma | 1998 |
Anticholinergic versus beta 2-agonist on gas exchange in COPD: a comparative study in 15 patients.
Topics: Administration, Inhalation; Adrenergic beta-Agonists; Albuterol; Bronchodilator Agents; Double-Blind | 1998 |
Effects of formoterol, salmeterol or oxitropium bromide on airway responses to salbutamol in COPD.
Topics: Adrenergic beta-Agonists; Adult; Albuterol; Bronchi; Bronchodilator Agents; Cross-Over Studies; Dose | 1998 |
Efficacy and tolerability of formoterol in elderly patients with reversible obstructive airways disease.
Topics: Administration, Inhalation; Aged; Aged, 80 and over; Albuterol; Bronchodilator Agents; Double-Blind | 1998 |
Bronchodilator delivery by metered-dose inhaler in mechanically ventilated COPD patients: influence of end-inspiratory pause.
Topics: Aged; Airway Resistance; Albuterol; Bronchodilator Agents; Dose-Response Relationship, Drug; Female; | 1998 |
Cardiac effects of formoterol and salmeterol in patients suffering from COPD with preexisting cardiac arrhythmias and hypoxemia.
Topics: Administration, Inhalation; Adrenergic beta-Agonists; Aged; Albuterol; Arrhythmias, Cardiac; Cross-O | 1998 |
Utility of transfer factor to detect different bronchodilator responses in patients with chronic obstructive pulmonary disease.
Topics: Aged; Albuterol; Analysis of Variance; Anti-Inflammatory Agents; Biomarkers; Bronchial Provocation T | 1998 |
Inhalation by nebulization of albuterol-ipratropium combination (Dey combination) is superior to either agent alone in the treatment of chronic obstructive pulmonary disease. Dey Combination Solution Study Group.
Topics: Adult; Aerosols; Aged; Aged, 80 and over; Albuterol; Albuterol, Ipratropium Drug Combination; Bronch | 1998 |
Effect of salbutamol on dynamic hyperinflation in chronic obstructive pulmonary disease patients.
Topics: Administration, Inhalation; Adrenergic beta-Agonists; Aged; Albuterol; Expiratory Reserve Volume; Fe | 1998 |
Early reversibility to salbutamol does not always predict bronchodilation after salmeterol in stable chronic obstructive pulmonary disease.
Topics: Adrenergic beta-Agonists; Adult; Albuterol; Bronchodilator Agents; Cross-Over Studies; Double-Blind | 1998 |
Comparison of the effects of salmeterol and ipratropium bromide on exercise performance and breathlessness in patients with stable chronic obstructive pulmonary disease.
Topics: Adrenergic beta-Agonists; Aged; Albuterol; Bronchodilator Agents; Exercise Tolerance; Humans; Ipratr | 1998 |
For COPD a combination of ipratropium bromide and albuterol sulfate is more effective than albuterol base.
Topics: Administration, Inhalation; Adult; Albuterol; Bronchodilator Agents; Double-Blind Method; Drug Thera | 1999 |
Oral bambuterol compared to inhaled salmeterol in patients with partially reversible chronic obstructive pulmonary disease.
Topics: Administration, Inhalation; Administration, Oral; Adult; Aged; Albuterol; Arrhythmias, Cardiac; Bron | 1999 |
Pharmacoeconomic evaluation of a combination of ipratropium plus albuterol compared with ipratropium alone and albuterol alone in COPD.
Topics: Adult; Aged; Aged, 80 and over; Albuterol; Bronchodilator Agents; Cost-Benefit Analysis; Double-Blin | 1999 |
Comparability of albuterol delivered by a piezoelectric device versus metered dose inhaler in patients with chronic obstructive airways disease.
Topics: Adolescent; Adult; Aged; Albuterol; Bronchodilator Agents; Cross-Over Studies; Double-Blind Method; | 1998 |
Comparison of the bronchodilator effects of salbutamol delivered via a metered-dose inhaler with spacer, a dry-powder inhaler, and a jet nebulizer in patients with chronic obstructive pulmonary disease.
Topics: Administration, Inhalation; Aged; Albuterol; Analysis of Variance; Bronchodilator Agents; Cross-Over | 1999 |
Efficacy of salmeterol xinafoate in the treatment of COPD.
Topics: Administration, Inhalation; Adrenergic beta-Agonists; Albuterol; Bronchodilator Agents; Double-Blind | 1999 |
The combination of ipratropium and albuterol optimizes pulmonary function reversibility testing in patients with COPD.
Topics: Adrenergic beta-Agonists; Albuterol; Bronchodilator Agents; Double-Blind Method; Drug Therapy, Combi | 1999 |
Lung function in infants with chronic pulmonary disease after severe adenoviral illness.
Topics: Adenoviridae Infections; Albuterol; Bronchodilator Agents; Child, Preschool; Chronic Disease; Humans | 1999 |
[Results of 30 days and 12 months treatment with salmeterol in patients with asthma and COPD].
Topics: Adrenergic beta-Agonists; Adult; Aged; Albuterol; Female; Humans; Lung Diseases, Obstructive; Male; | 1999 |
Effects of salmeterol on arterial blood gases in patients with stable chronic obstructive pulmonary disease. Comparison with albuterol and ipratropium.
Topics: Administration, Inhalation; Adrenergic beta-Agonists; Aged; Albuterol; Analysis of Variance; Area Un | 1999 |
Formoterol and salmeterol in partially reversible chronic obstructive pulmonary disease: A crossover, placebo-controlled comparison of onset and duration of action.
Topics: Administration, Inhalation; Albuterol; Bronchodilator Agents; Cross-Over Studies; Double-Blind Metho | 1999 |
An empirical comparison of the St George's Respiratory Questionnaire (SGRQ) and the Chronic Respiratory Disease Questionnaire (CRQ) in a clinical trial setting.
Topics: Adult; Aged; Albuterol; Bronchodilator Agents; Double-Blind Method; Feasibility Studies; Female; Hum | 1999 |
Salmeterol versus slow-release theophylline in patients with reversible obstructive pulmonary disease.
Topics: Adrenergic beta-Agonists; Albuterol; Bronchodilator Agents; Delayed-Action Preparations; Humans; Lun | 1999 |
Acute effect of pretreatment with single conventional dose of salmeterol on dose-response curve to oxitropium bromide in chronic obstructive pulmonary disease.
Topics: Administration, Inhalation; Aged; Albuterol; Bronchodilator Agents; Cholinergic Antagonists; Dose-Re | 1999 |
Inflammatory markers in acute exacerbations of obstructive pulmonary disease: predictive value in relation to smoking history.
Topics: Acute Disease; Adrenergic beta-Agonists; Adult; Aged; Aged, 80 and over; Albuterol; Anti-Inflammator | 1999 |
Does inhaled albuterol improve diaphragmatic contractility in patients with chronic obstructive pulmonary disease?
Topics: Action Potentials; Administration, Inhalation; Adrenergic beta-Agonists; Aged; Albuterol; Bronchodil | 1999 |
Bronchodilator delivery by metered-dose inhaler in mechanically ventilated COPD patients: influence of tidal volume.
Topics: Administration, Inhalation; Adrenergic beta-Agonists; Aged; Airway Resistance; Albuterol; Analysis o | 1999 |
Does high dose ipratropium bromide added to salbutamol improve pulmonary function for patients with chronic obstructive airways disease in the emergency department?
Topics: Adrenergic beta-Agonists; Adult; Albuterol; Bronchodilator Agents; Cholinergic Antagonists; Double-B | 2000 |
Long-term treatment of chronic obstructive pulmonary disease with salmeterol and the additive effect of ipratropium.
Topics: Aged; Albuterol; Bronchodilator Agents; Double-Blind Method; Drug Therapy, Combination; Female; Huma | 2000 |
Early use of non-invasive ventilation for acute exacerbations of chronic obstructive pulmonary disease on general respiratory wards: a multicentre randomised controlled trial.
Topics: Aged; Albuterol; Bronchodilator Agents; Female; Hospital Mortality; Humans; Hydrogen-Ion Concentrati | 2000 |
Safety of sputum induction in chronic obstructive pulmonary disease.
Topics: Aerosols; Aged; Albuterol; Bronchoconstriction; Bronchodilator Agents; Female; Forced Expiratory Vol | 2000 |
Bronchodilator therapy with metered-dose inhaler and spacer versus nebulizer in mechanically ventilated patients: comparison of magnitude and duration of response.
Topics: Administration, Inhalation; Aerosols; Airway Resistance; Albuterol; Bronchodilator Agents; Cross-Ove | 2000 |
[efficacy and safety of salmeterol in long-term therapy in patients with chronic obstructive airway diseases].
Topics: Administration, Inhalation; Adolescent; Adrenergic beta-Agonists; Adult; Aged; Albuterol; Bronchodil | 2000 |
Effectiveness and acceptability of a domiciliary multidrug inhalation treatment in elderly patients with chronic airflow obstruction: metered dose inhaler versus jet nebulizer.
Topics: Administration, Inhalation; Aged; Albuterol; Anti-Asthmatic Agents; Asthma; Bronchodilator Agents; C | 2000 |
Bronchodilator delivery by metered-dose inhaler in mechanically ventilated COPD patients: influence of flow pattern.
Topics: Adrenergic beta-Agonists; Aged; Albuterol; Bronchodilator Agents; Cross-Over Studies; Female; Humans | 2000 |
The cumulative effect of long-acting bronchodilators, exercise, and inspiratory muscle training on the perception of dyspnea in patients with advanced COPD.
Topics: Administration, Inhalation; Albuterol; Bronchodilator Agents; Delayed-Action Preparations; Dyspnea; | 2000 |
Randomized trial of the use of heliox as a driving gas for updraft nebulization of bronchodilators in the emergent treatment of acute exacerbations of chronic obstructive pulmonary disease.
Topics: Aerosols; Albuterol; Bronchodilator Agents; Emergencies; Female; Forced Expiratory Volume; Helium; H | 2000 |
Effect of anti-asthmatic drugs on the response to inhaled endotoxin.
Topics: Administration, Inhalation; Adult; Albuterol; Anti-Asthmatic Agents; Bronchodilator Agents; Cross-Ov | 2000 |
Lung function improvement in smokers suffering from COPD with zafirlukast, a CysLT(1)-receptor antagonist.
Topics: Aged; Albuterol; Anti-Asthmatic Agents; Area Under Curve; Bronchodilator Agents; Cross-Over Studies; | 2000 |
The spirometric efficacy of once-daily dosing with tiotropium in stable COPD: a 13-week multicenter trial. The US Tiotropium Study Group.
Topics: Aged; Albuterol; Bronchodilator Agents; Cholinergic Antagonists; Double-Blind Method; Dyspnea; Femal | 2000 |
Additive effects of salmeterol and fluticasone or theophylline in COPD.
Topics: Administration, Inhalation; Adrenergic beta-Agonists; Aged; Albuterol; Androstadienes; Bronchodilato | 2000 |
Regular versus as-needed short-acting inhaled beta-agonist therapy for chronic obstructive pulmonary disease.
Topics: Administration, Inhalation; Adrenergic beta-Agonists; Aged; Albuterol; Cross-Over Studies; Double-Bl | 2001 |
Effect of inspiratory flow rate on beta2-agonist induced bronchodilation in mechanically ventilated COPD patients.
Topics: Adrenergic beta-Agonists; Aged; Albuterol; Analysis of Variance; Bronchi; Cross-Over Studies; Female | 2001 |
The role of domiciliary nebulizers in managing patients with severe COPD.
Topics: Administration, Inhalation; Aged; Albuterol; Bronchodilator Agents; Cross-Over Studies; Double-Blind | 2001 |
Use of a long-acting inhaled beta2-adrenergic agonist, salmeterol xinafoate, in patients with chronic obstructive pulmonary disease.
Topics: Adrenergic beta-Agonists; Albuterol; Analysis of Variance; Bronchodilator Agents; Cholinergic Antago | 2001 |
In patients with COPD, treatment with a combination of formoterol and ipratropium is more effective than a combination of salbutamol and ipratropium : a 3-week, randomized, double-blind, within-patient, multicenter study.
Topics: Adult; Aged; Aged, 80 and over; Albuterol; Bronchodilator Agents; Cross-Over Studies; Double-Blind M | 2001 |
Therapeutic equivalence of the Sofotec Novolizer to established standard devices in COPD and asthma.
Topics: Albuterol; Asthma; Bronchodilator Agents; Budesonide; Humans; Lung Diseases, Obstructive; Nebulizers | 2001 |
Salmeterol plus theophylline combination therapy in the treatment of COPD.
Topics: Adrenergic beta-Agonists; Aged; Aged, 80 and over; Albuterol; Bronchodilator Agents; Double-Blind Me | 2001 |
Alternative methods for assessing bronchodilator reversibility in chronic obstructive pulmonary disease.
Topics: Aged; Albuterol; Analysis of Variance; Bronchodilator Agents; Chronic Disease; Female; Forced Expira | 2001 |
Rapid onset of bronchodilation in COPD: a placebo-controlled study comparing formoterol (Foradil Aerolizer) with salbutamol (Ventodisk).
Topics: Adult; Aerosols; Aged; Albuterol; Area Under Curve; Bronchodilator Agents; Cross-Over Studies; Doubl | 2001 |
Wearing a noseclip improves nebulised aerosol delivery.
Topics: Administration, Inhalation; Adult; Aerosols; Albuterol; Bronchodilator Agents; Female; Humans; Lung | 2001 |
[Parasympathicolytic drugs in treatment of obstructive lung diseases (author's transl)].
Topics: Adrenergic beta-Agonists; Airway Obstruction; Albuterol; Asthma; Atropine Derivatives; Cromolyn Sodi | 1979 |
[Use of aerosols in obstructive respiratory tract diseases. Clinical-pharmacological studies using fenoterol, salbutamol, ipratropium bromide and terbutaline].
Topics: Adult; Aerosols; Aged; Albuterol; Atropine Derivatives; Bronchi; Clinical Trials as Topic; Ethanolam | 1977 |
Cardiac and pulmonary effects of therapy with albuterol and isoproterenol.
Topics: Adolescent; Adult; Albuterol; Blood Pressure; Clinical Trials as Topic; Double-Blind Method; Forced | 1978 |
Comparison of oral salbutamol and ephedrine in chronic obstructive pulmonary disease.
Topics: Adolescent; Adult; Aged; Albuterol; Child; Chronic Disease; Clinical Trials as Topic; Double-Blind M | 1978 |
[Therapeutic action of salbutamol as compared with orciprenaline in patients with chronic obstructive bronchopneumopathy. Double-blind study].
Topics: Adult; Aged; Albuterol; Clinical Trials as Topic; Drug Evaluation; Humans; Lung Diseases, Obstructiv | 1976 |
Response to oral corticosteroid in patients with chronic obstructive pulmonary disease.
Topics: Aged; Albuterol; Eosinophils; Female; Forced Expiratory Volume; Humans; Immunoglobulin E; Ipratropiu | 1992 |
Is xamoterol safe in chronic airflow obstruction?
Topics: Adrenergic beta-Agonists; Aged; Albuterol; Double-Blind Method; Female; Hemodynamics; Humans; Lung D | 1992 |
Inhaled salmeterol in the treatment of patients with moderate to severe reversible obstructive airways disease--a 3-month comparison of the efficacy and safety of twice-daily salmeterol (100 micrograms) with salmeterol (50 micrograms).
Topics: Administration, Inhalation; Adrenergic beta-Antagonists; Adult; Aged; Aged, 80 and over; Albuterol; | 1992 |
Single-dose and steady-state effects of controlled-release salbutamol on drug level and airflow obstruction in patients with asthma.
Topics: Adolescent; Adult; Albuterol; Asthma; Delayed-Action Preparations; Dose-Response Relationship, Drug; | 1992 |
Effects of corticosteroids on bronchodilator action in chronic obstructive lung disease.
Topics: Administration, Inhalation; Aged; Albuterol; Budesonide; Dose-Response Relationship, Drug; Drug Ther | 1992 |
Two-year bronchodilator treatment in patients with mild airflow obstruction. Contradictory effects on lung function and quality of life.
Topics: Albuterol; Female; Forced Expiratory Volume; Humans; Ipratropium; Lung Diseases, Obstructive; Male; | 1992 |
A long-term prospective assessment of home nebulizer treatment.
Topics: Adult; Aged; Albuterol; Ambulatory Care; Asthma; Bronchodilator Agents; Drug Combinations; Humans; I | 1992 |
Impedance measurement during air and helium-oxygen breathing before and after salbutamol in COPD patients.
Topics: Adult; Aged; Airway Resistance; Albuterol; Female; Helium; Humans; Lung Compliance; Lung Diseases, O | 1992 |
Comparison of terbutaline Turbuhaler and albuterol chlorofluorocarbon (CFC) inhaler in middle-aged and elderly patients with obstructive lung disease.
Topics: Administration, Inhalation; Aged; Albuterol; Female; Humans; Lung Diseases, Obstructive; Male; Middl | 1992 |
Theophylline and salbutamol improve pulmonary function in patients with irreversible chronic obstructive pulmonary disease.
Topics: Administration, Inhalation; Administration, Oral; Aged; Albuterol; Double-Blind Method; Drug Therapy | 1992 |
Dose response to inhaled salbutamol in chronic obstructive airways disease.
Topics: Administration, Inhalation; Adult; Aged; Aged, 80 and over; Albuterol; Bronchi; Dose-Response Relati | 1991 |
Effect of controlled-release salbutamol in predominantly non-reversible chronic airflow obstruction.
Topics: Albuterol; Delayed-Action Preparations; Double-Blind Method; Drug Administration Schedule; Female; H | 1991 |
Comparison of ipratropium bromide and albuterol in chronic obstructive pulmonary disease: a three-center study.
Topics: Aerosols; Albuterol; Analysis of Variance; Double-Blind Method; Female; Forced Expiratory Volume; He | 1991 |
The protective effect of a beta 2 agonist against excessive airway narrowing in response to bronchoconstrictor stimuli in asthma and chronic obstructive lung disease.
Topics: Adult; Aged; Airway Obstruction; Albuterol; Asthma; Bronchoconstriction; Dose-Response Relationship, | 1991 |
Acute and long-term effectiveness of tulobuterol inhaler, a new beta 2-agonist, in the treatment of asthma.
Topics: Adolescent; Adrenergic beta-Agonists; Adult; Aged; Albuterol; Asthma; Bronchodilator Agents; Double- | 1990 |
Long-term efficacy of formoterol compared to salbutamol.
Topics: Administration, Inhalation; Adolescent; Adrenergic beta-Agonists; Adult; Aged; Airway Resistance; Al | 1990 |
Mechanism of bronchodilator effect in chronic airflow limitation.
Topics: Activities of Daily Living; Aged; Albuterol; Drug Therapy, Combination; Dyspnea; Forced Expiratory V | 1991 |
Metered dose inhalers for bronchodilator delivery in intubated, mechanically ventilated patients.
Topics: Aerosols; Aged; Albuterol; Asthma; Costs and Cost Analysis; Female; Humans; Intubation, Intratrachea | 1991 |
Severe exacerbations of COPD and asthma. Incremental benefit of adding ipratropium to usual therapy.
Topics: Administration, Inhalation; Albuterol; Aminophylline; Anti-Bacterial Agents; Asthma; Atropine Deriva | 1990 |
Home nebulizers: can optimal therapy be predicted by laboratory studies?
Topics: Adult; Aged; Albuterol; Asthma; Double-Blind Method; Female; Humans; Ipratropium; Lung Diseases, Obs | 1990 |
[Inhalation therapy with selective beta 2-sympathomimetic drugs. Effect of pirbuterol administered via the Autohaler and salbutamol administered via the Diskhaler in obstructive respiratory tract disease].
Topics: Adult; Aerosols; Aged; Airway Resistance; Albuterol; Bronchodilator Agents; Ethanolamines; Female; H | 1990 |
Clinical and pharmacological study of a novel controlled release preparation of salbutamol.
Topics: Adult; Aged; Albuterol; Delayed-Action Preparations; Double-Blind Method; Female; Forced Expiratory | 1990 |
Comparative evaluation of cardioselectivity of metoprolol OROS and atenolol: a double-blind, placebo-controlled crossover study.
Topics: Adolescent; Adult; Aged; Airway Resistance; Albuterol; Atenolol; Clinical Trials as Topic; Double-Bl | 1990 |
Comparison of terbutaline via the Nebuhaler and salbutamol via the Volumatic: theory and practice.
Topics: Albuterol; Female; Forced Expiratory Volume; Humans; Lung Diseases, Obstructive; Male; Middle Aged; | 1990 |
Combination of theophylline and salbutamol for arrhythmias in severe COPD.
Topics: Aged; Albuterol; Cardiac Complexes, Premature; Drug Therapy, Combination; Female; Humans; Lung Disea | 1987 |
High-dose inhaled albuterol in severe chronic airflow limitation.
Topics: Aged; Albuterol; Cardiac Complexes, Premature; Dose-Response Relationship, Drug; Female; Forced Expi | 1988 |
A comparison of the effect of ipratropium and albuterol in the treatment of chronic obstructive airway disease.
Topics: Administration, Inhalation; Aerosols; Albuterol; Atropine Derivatives; Blood Pressure; Female; Force | 1989 |
Nebulised salbutamol with and without ipratropium bromide in acute airflow obstruction.
Topics: Acute Disease; Adolescent; Adult; Aged; Aged, 80 and over; Albuterol; Asthma; Atropine Derivatives; | 1989 |
Nebulizer vs spacer for bronchodilator delivery in patients hospitalized for acute exacerbations of COPD.
Topics: Administration, Inhalation; Aged; Aged, 80 and over; Albuterol; Blood Pressure; Double-Blind Method; | 1989 |
High dose salbutamol in chronic airflow obstruction: comparison of nebulizer with Rotacaps.
Topics: Administration, Inhalation; Adult; Aged; Aged, 80 and over; Albuterol; Double-Blind Method; Female; | 1989 |
[Theophylline plus salbutamol in chronic bronchial obstruction. The additive effects of combination therapy in comparison with salbutamol monotherapy].
Topics: Adult; Albuterol; Clinical Trials as Topic; Double-Blind Method; Drug Therapy, Combination; Female; | 1989 |
[Clinico-pharmacologic study of a new sustained-release oral salbutamol preparation in patients with obstructive airway disease].
Topics: Adult; Albuterol; Blood Glucose; Clinical Trials as Topic; Delayed-Action Preparations; Double-Blind | 1989 |
Theophylline and salbutamol in combination in patients with obstructive pulmonary disease and concurrent heart disease: effect on cardiac arrhythmias.
Topics: Aged; Albuterol; Arrhythmias, Cardiac; Clinical Trials as Topic; Delayed-Action Preparations; Drug T | 1989 |
Measuring functional status in chronic lung disease: conclusions from a randomized control trial.
Topics: Albuterol; Analysis of Variance; Drug Therapy, Combination; Exercise Test; Humans; Lung; Lung Diseas | 1989 |
Treatment of reversible chronic airways obstruction with doxofylline compared with slow-release theophylline: a double-blind, randomized, multicentre trial.
Topics: Adolescent; Adult; Aged; Albuterol; Delayed-Action Preparations; Double-Blind Method; Female; Humans | 1989 |
Should study subjects see their previous responses: data from a randomized control trial.
Topics: Administration, Oral; Aged; Albuterol; Double-Blind Method; Drug Therapy, Combination; Female; Human | 1989 |
Double-blind comparison of tulobuterol and salbutamol in chronic obstructive pulmonary disease.
Topics: Adrenergic beta-Agonists; Adult; Albuterol; Double-Blind Method; Drug Tolerance; Forced Expiratory V | 1986 |
Broxaterol (Z.1170), a new oral beta 2-agonist compared with salbutamol.
Topics: Adrenergic beta-Agonists; Adult; Aged; Albuterol; Double-Blind Method; Female; Hemodynamics; Humans; | 1987 |
Theophylline as a bronchodilator in COPD and its combination with inhaled beta-adrenergic drugs.
Topics: Adrenergic beta-Agonists; Albuterol; Animals; Asthma; Bronchi; Bronchitis; Clinical Trials as Topic; | 1987 |
A comparison of the bronchodilator effects of broxaterol and salbutamol.
Topics: Administration, Inhalation; Adrenergic beta-Agonists; Adult; Aged; Albuterol; Asthma; Blood Pressure | 1988 |
[Comparative studies on the effectiveness of inhalant beta 2 mimetics therapy in patients with obstructive respiratory disorders].
Topics: Adrenergic beta-Agonists; Adult; Aerosols; Aged; Albuterol; Bronchodilator Agents; Double-Blind Meth | 1988 |
A comparison of the bronchodilating effects of a beta-2 adrenergic agent (albuterol) and an anticholinergic agent (ipratropium bromide), given by aerosol alone or in sequence.
Topics: Aerosols; Aged; Albuterol; Atropine Derivatives; Bronchodilator Agents; Clinical Trials as Topic; Do | 1986 |
Clinical physiological data on the bronchodilator effect of Duovent versus salbutamol in chronic obstructive lung disease.
Topics: Albuterol; Atropine Derivatives; Bronchodilator Agents; Clinical Trials as Topic; Drug Combinations; | 1986 |
Comparison between fenoterol/ipratropium bromide combinations and salbutamol administered as nebulizer solution assessing dose-response and duration of action.
Topics: Adolescent; Adult; Albuterol; Atropine Derivatives; Cardiovascular System; Dose-Response Relationshi | 1986 |
Salbutamol and ipratropium in partially reversible airway obstruction.
Topics: Adult; Albuterol; Atropine Derivatives; Clinical Trials as Topic; Double-Blind Method; Drug Therapy, | 1987 |
Comparison of a fenoterol/ipratropium combination with salbutamol from metered dose inhalers in subjects with chronic partially reversible airways obstruction.
Topics: Aged; Albuterol; Atropine Derivatives; Drug Therapy, Combination; Fenoterol; Humans; Ipratropium; Lu | 1987 |
Effect of three different bronchodilators during an exacerbation of chronic obstructive pulmonary disease.
Topics: Aged; Albuterol; Aminophylline; Atropine Derivatives; Clinical Trials as Topic; Dose-Response Relati | 1988 |
A comparison of salbutamol and ipratropium in chronic bronchitis and chronic airflow limitation.
Topics: Aged; Albuterol; Atropine Derivatives; Bronchitis; Chronic Disease; Clinical Trials as Topic; Double | 1988 |
Acute response to bronchodilator. An imperfect guide for bronchodilator therapy in chronic airflow limitation.
Topics: Administration, Inhalation; Administration, Oral; Aged; Albuterol; Analysis of Variance; Clinical Tr | 1988 |
Interactive effects of systemically administered salbutamol and aminophylline in patients with chronic obstructive pulmonary disease.
Topics: Albuterol; Aminophylline; Drug Therapy, Combination; Forced Expiratory Volume; Heart Rate; Humans; I | 1988 |
Regional distribution of ventilation in chronic obstructive lung disease and the effect of salbutamol.
Topics: Adult; Aged; Albuterol; Female; Humans; Lung Diseases, Obstructive; Male; Middle Aged; Radionuclide | 1988 |
Hypokalaemic and electrocardiographic effects of aminophylline and salbutamol in obstructive airways disease.
Topics: Administration, Inhalation; Adult; Albuterol; Aminophylline; Arrhythmias, Cardiac; Asthma; Clinical | 1987 |
Effects of beta-agonists on breathlessness and exercise tolerance in patients with chronic obstructive pulmonary disease.
Topics: Aged; Albuterol; Clenbuterol; Clinical Trials as Topic; Dyspnea; Ethanolamines; Forced Expiratory Vo | 1986 |
The hemodynamic effects of aminophylline and salbutamol alone and in combination.
Topics: Adult; Albuterol; Aminophylline; Blood Pressure; Clinical Trials as Topic; Drug Therapy, Combination | 1986 |
Comparison of inhaled albuterol powder and aerosol in asthma.
Topics: Administration, Inhalation; Adolescent; Adult; Aerosols; Aged; Albuterol; Asthma; Child; Clinical Tr | 1987 |
Comparison of domiciliary nebulized salbutamol and salbutamol from a metered-dose inhaler in stable chronic airflow limitation.
Topics: Adult; Aerosols; Aged; Albuterol; Clinical Trials as Topic; Dose-Response Relationship, Drug; Double | 1987 |
A comparison of responses to albuterol delivered by two aerosol devices.
Topics: Aerosols; Albuterol; Female; Forced Expiratory Flow Rates; Forced Expiratory Volume; Humans; Lung Di | 1986 |
Comparison of tremor responses to orally administered albuterol and terbutaline.
Topics: Administration, Oral; Aged; Albuterol; Forced Expiratory Volume; Humans; Lung Diseases, Obstructive; | 1986 |
Effect of nifedipine on salbutamol-induced bronchodilation in partially reversible airway obstruction.
Topics: Adult; Aged; Airway Resistance; Albuterol; Double-Blind Method; Drug Interactions; Forced Expiratory | 1986 |
Salbutamol plus beclomethasone dipropionate (Ventolin Flogo) vs. fenoterol (Dosberotec) in chronic obstructive lung disease therapeutic strategy: a 4-week clinical trial.
Topics: Aged; Albuterol; Beclomethasone; Clinical Trials as Topic; Drug Combinations; Ethanolamines; Fenoter | 1985 |
Long-term therapy with sustained-release theophylline.
Topics: Adult; Aged; Albuterol; Clinical Trials as Topic; Delayed-Action Preparations; Double-Blind Method; | 1985 |
Serum theophylline and ventilatory function in chronic obstructive lung disease. Comparison between two slow-release formulations of theophylline.
Topics: Albuterol; Clinical Trials as Topic; Delayed-Action Preparations; Double-Blind Method; Female; Human | 1985 |
The efficacy of orally administered theophylline, inhaled salbutamol, and a combination of the two as chronic therapy in the management of chronic bronchitis with reversible air-flow obstruction.
Topics: Administration, Oral; Aerosols; Aged; Albuterol; Bronchitis; Delayed-Action Preparations; Drug Thera | 1985 |
Effects of the calcium antagonist tiapamil on pulmonary gas exchange in patients with chronic obstructive pulmonary disease who receive salbutamol.
Topics: Adult; Aged; Airway Obstruction; Albuterol; Double-Blind Method; Drug Evaluation; Drug Interactions; | 1985 |
177 other studies available for albuterol and Obstructive Lung Diseases
| Article | Year |
|---|---|
Financial effect of converting ipratropium-albuterol therapy from inhalers to nebulizer treatments at an academic health system.
Topics: Administration, Inhalation; Albuterol; Bronchodilator Agents; Chemistry, Pharmaceutical; Cost-Benefi | 2016 |
Tidal changes in respiratory resistance are sensitive indicators of airway obstruction in children.
Topics: Airway Resistance; Albuterol; Anthropometry; Asthma; Bronchodilator Agents; Child; Child, Preschool; | 2016 |
Residual Volume and Total Lung Capacity to Assess Reversibility in Obstructive Lung Disease.
Topics: Administration, Inhalation; Aged; Albuterol; Bronchodilator Agents; Female; Forced Expiratory Volume | 2016 |
Effect of educational and policy interventions on institutional utilization of wet nebulization respiratory drugs and portable inhalers.
Topics: Administration, Inhalation; Albuterol; Asthma; Bronchodilator Agents; Health Services; Hospital Bed | 2008 |
A novel, versatile valved holding chamber for delivering inhaled medications to neonates and small children: laboratory simulation of delivery options.
Topics: Administration, Inhalation; Aerosols; Albuterol; Bronchodilator Agents; Child, Preschool; Equipment | 2010 |
Evaluation of the effects of the R- and S-enantiomers of salbutamol on equine isolated bronchi.
Topics: Albuterol; Animals; Bronchi; Bronchodilator Agents; Female; Histamine; Horse Diseases; Horses; Lung | 2011 |
Breath-actuated nebulizer versus small-volume nebulizer: efficacy, safety, and satisfaction.
Topics: Albuterol; Bronchodilator Agents; Female; Humans; Ipratropium; Lung Diseases, Obstructive; Male; Neb | 2012 |
Pulmonary outcome in adolescents of extreme preterm birth: a regional cohort study.
Topics: Adolescent; Albuterol; Asthma; Bronchial Hyperreactivity; Bronchial Provocation Tests; Bronchopulmon | 2004 |
Assessment of pulmonary air trapping and obstruction in expiration: an experimental MRI study.
Topics: Acetylcholine; Albuterol; Animals; Bronchodilator Agents; Lung Diseases, Obstructive; Magnetic Reson | 2005 |
Symposium on reversible chronic obstructive airway disease and the clinical application of albuterol. January 28, 1981, Washington, D.C.
Topics: Albuterol; Congresses as Topic; Humans; Lung Diseases, Obstructive | 1981 |
[Fenoterol in the treatment of bronchial obstruction in chronic asthmatiform bronchitis].
Topics: Adult; Aged; Albuterol; Bronchitis; Ethanolamines; Female; Fenoterol; Humans; Ipratropium; Lung Dise | 1982 |
Reversible airflow obstruction: clinical spectrum and responsiveness to anticholinergic drugs.
Topics: Adult; Aged; Airway Resistance; Albuterol; Asthma; Atropine Derivatives; Bronchitis; Female; Forced | 1984 |
Asthma vs. non-specific reversible airflow obstruction: clinical features and responsiveness to anticholinergic drugs.
Topics: Adolescent; Adult; Aged; Airway Resistance; Albuterol; Asthma; Atropine Derivatives; Bronchial Provo | 1984 |
Oxygen as a driving gas for nebulizers: safe or dangerous.
Topics: Aerosols; Albuterol; Humans; Lung Diseases, Obstructive; Oxygen | 1984 |
[Spirometric modifications induced by bronchography. Effects of Salbutamol].
Topics: Adult; Albuterol; Anesthesia, Local; Bronchography; Female; Humans; Lidocaine; Lung Diseases, Obstru | 1984 |
Asthma and irreversible airflow obstruction.
Topics: Adult; Age Factors; Albuterol; Asthma; Chronic Disease; Female; Forced Expiratory Volume; Humans; Lu | 1984 |
Acute effect of inhaled salbutamol on mucociliary clearance in health and chronic bronchitis.
Topics: Adult; Aerosols; Aged; Airway Resistance; Albuterol; Bronchitis; Chronic Disease; Cilia; Double-Blin | 1984 |
The place for albuterol aerosol in chronic obstructive airway disease: maximizing its use.
Topics: Aerosols; Albuterol; Cromolyn Sodium; Drug Synergism; Humans; Lung Diseases, Obstructive; Respirator | 1981 |
Nebulised salbutamol and angina.
Topics: Aerosols; Aged; Albuterol; Angina Pectoris; Humans; Lung Diseases, Obstructive; Male; Middle Aged | 1982 |
Effects of cold air hyperpnea in patients with chronic obstructive lung disease.
Topics: Aged; Airway Resistance; Albuterol; Bronchi; Cold Temperature; Female; Fenoterol; Forced Expiratory | 1983 |
Compliance with aerosol therapy in chronic obstructive lung disease.
Topics: Adolescent; Adult; Aerosols; Aged; Albuterol; Beclomethasone; Bronchodilator Agents; Female; Humans; | 1981 |
Lack of response to bronchodilator of airway obstruction after mechanical ventilation in the newborn.
Topics: Albuterol; Bronchodilator Agents; Humans; Infant; Infant, Newborn; Lung Diseases, Obstructive; Lung | 1982 |
Chronic severe bronchospasm in adults. Treatment in general practice.
Topics: Adolescent; Adult; Aerosols; Aged; Albuterol; Bronchial Spasm; Family Practice; Humans; Lung Disease | 1982 |
Atropine methonitrate and salbutamol in chronic airways obstruction: peak effect and duration of action.
Topics: Adult; Aged; Albuterol; Atropine Derivatives; Drug Combinations; Female; Forced Expiratory Volume; H | 1982 |
The effects of nebulized salbutamol on lung function and exercise tolerance in patients with severe airflow obstruction.
Topics: Aged; Albuterol; Female; Humans; Lung; Lung Diseases, Obstructive; Male; Middle Aged; Physical Exert | 1982 |
The influence of theophylline on maximal response to salbutamol in severe chronic obstructive pulmonary disease.
Topics: Aged; Albuterol; Blood Pressure; Dose-Response Relationship, Drug; Drug Interactions; Forced Expirat | 1982 |
[Comparative study of the bronchodilator effect of trimethoquinol and salbutamol].
Topics: Adult; Albuterol; Analysis of Variance; Double-Blind Method; Drug Evaluation; Female; Heart Rate; Hu | 1982 |
Hemodynamic and ventilatory effects of intravenous salbutamol in patients affected by cold.
Topics: Adult; Albuterol; Blood Pressure; Chronic Disease; Heart Rate; Humans; Infusions, Parenteral; Lung D | 1980 |
Salbutamol and cardiac arrhythmias.
Topics: Aged; Albuterol; Arrhythmias, Cardiac; Electrocardiography; Female; Heart Rate; Humans; Infusions, P | 1981 |
[Sympathicomimetics and development of tolerance (author's transl)].
Topics: Airway Resistance; Albuterol; Drug Tolerance; Hemodynamics; Humans; Lung Diseases, Obstructive; Symp | 1981 |
[Salbutamol in children with CARA; a comparison of administration with tablets and with the Rotahaler].
Topics: Adolescent; Aerosols; Albuterol; Child; Evaluation Studies as Topic; Female; Humans; Lung Diseases, | 1981 |
Acute effects of albuterol aerosol in reversible obstructive airway disease.
Topics: Albuterol; Humans; Isoproterenol; Lung Diseases, Obstructive; Respiratory Function Tests; Time Facto | 1981 |
[Evaluation of the bronchodilating effect of TH 1165 A and of salbutamol in patients with spastic obstructive ventilatory syndrome].
Topics: Adult; Aged; Albuterol; Asthma; Bronchi; Bronchial Spasm; Ethanolamines; Fenoterol; Humans; Lung Dis | 1981 |
[Fenoterol in the diagnosis and treatment of reversible bronchospasm].
Topics: Adult; Albuterol; Asthma; Bronchial Spasm; Ethanolamines; Female; Fenoterol; Humans; Lung Diseases, | 1981 |
[New developments in the field of bronchospasmolytics].
Topics: Albuterol; Aminophylline; Bronchial Spasm; Bronchodilator Agents; Clenbuterol; Fenoterol; Glucocorti | 1980 |
Cyclic AMP enhancing drugs modulate eicosanoid release from human alveolar macrophages.
Topics: 1-Methyl-3-isobutylxanthine; Adult; Albuterol; Bronchoalveolar Lavage Fluid; Cyclic AMP; Cyclic GMP; | 1994 |
Forced oscillation technique vs spirometry to assess bronchodilatation in patients with asthma and COPD.
Topics: Airway Resistance; Albuterol; Asthma; Female; Forced Expiratory Volume; Humans; Lung Diseases, Obstr | 1995 |
COPD in the elderly. A reversible cause of functional impairment.
Topics: Administration, Inhalation; Age Factors; Aged; Albuterol; Bronchodilator Agents; Female; Humans; Lun | 1995 |
[Kombipek in the therapy of patients with broncho-obstructive lung diseases].
Topics: Adult; Albuterol; Bronchodilator Agents; Delayed-Action Preparations; Drug Combinations; Drug Evalua | 1995 |
Changing practices in COPD. A new pharmacologic treatment algorithm.
Topics: Administration, Inhalation; Albuterol; Algorithms; Bronchodilator Agents; Drug Administration Schedu | 1995 |
Contact dermatitis from salbutamol.
Topics: Aged; Albuterol; Dermatitis, Allergic Contact; Drug Eruptions; Facial Dermatoses; Humans; Lung Disea | 1994 |
Bronchodilator delivery by metered-dose inhaler in ventilator-supported patients.
Topics: Administration, Inhalation; Aged; Airway Resistance; Albuterol; Dose-Response Relationship, Drug; Hu | 1995 |
[Broncholytic activity of dose-adjusted aerosols in active respiratory tuberculosis].
Topics: Adult; Aerosols; Albuterol; Bronchodilator Agents; Cromolyn Sodium; Drug Combinations; Female; Fenot | 1995 |
The influence of age, diagnosis, and gender on proper use of metered-dose inhalers.
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Albuterol; Asthma; Female; Humans; Inspiratory Capacity | 1994 |
Bronchial responsiveness and acute bronchodilator response in chronic obstructive pulmonary disease and diffuse panbronchiolitis.
Topics: Aged; Albuterol; Bronchial Provocation Tests; Bronchiolitis; Bronchoconstriction; Female; Forced Exp | 1994 |
Assessment of reversibility of airflow obstruction.
Topics: Airway Resistance; Albuterol; Female; Humans; Lung Diseases, Obstructive; Lung Volume Measurements; | 1994 |
[Effect of vaporizing high doses of ipratropium bromide on lung ventilation in patients with chronic obstructive pulmonary disease and bronchial asthma].
Topics: Albuterol; Asthma; Drug Administration Schedule; Forced Expiratory Flow Rates; Forced Expiratory Vol | 1994 |
[Increasing physical endurance with salmeterol].
Topics: Administration, Inhalation; Adult; Aged; Albuterol; Anaerobic Threshold; Bronchodilator Agents; Exer | 1994 |
Is the short-term response to inhaled beta-adrenergic agonist sensitive or specific for distinguishing between asthma and COPD?
Topics: Administration, Inhalation; Aged; Albuterol; Asthma; Diagnosis, Differential; Forced Expiratory Volu | 1994 |
Effect of albuterol nebulization on peripheral WBC counts.
Topics: Administration, Inhalation; Adult; Albuterol; Asthma; Emergencies; Female; Humans; Leukocyte Count; | 1994 |
[Becotide rotadisks 0.1 mg/0.2 mg/0.4 mg and sultanol rotadisks 0.2 mg/0.4 mg, powder for dry inhalation with the Diskhaler].
Topics: Adult; Albuterol; Beclomethasone; Child; Dose-Response Relationship, Drug; Humans; Lung Diseases, Ob | 1993 |
Effects of correcting arterial hypoxaemia on respiratory resistance in patients with chronic obstructive pulmonary disease.
Topics: Adult; Aged; Airway Resistance; Albuterol; Female; Humans; Hypoxia; Lung; Lung Diseases, Obstructive | 1993 |
A statistical approach for assessment of bronchodilator responsiveness in pulmonary function testing.
Topics: Aerosols; Albuterol; Bronchoconstriction; Bronchodilator Agents; Female; Forced Expiratory Volume; H | 1993 |
[Response to inhaled bronchodilators in chronic airway obstruction].
Topics: Administration, Inhalation; Adult; Aged; Albuterol; Bronchodilator Agents; Female; Forced Expiratory | 1993 |
The daily energy expenditure in stable chronic obstructive pulmonary disease.
Topics: Administration, Inhalation; Adrenergic beta-Agonists; Aged; Albuterol; Basal Metabolism; Bronchodila | 1996 |
Bronchodilating effects of combined therapy with clinical dosages of ipratropium bromide and salbutamol for stable COPD.
Topics: Administration, Inhalation; Adrenergic beta-Agonists; Albuterol; Atropine; Bronchi; Bronchodilator A | 1996 |
Bronchodilating effects of combined therapy with clinical dosages of ipratropium bromide and salbutamol for stable COPD.
Topics: Administration, Inhalation; Adrenergic beta-Agonists; Albuterol; Bronchi; Bronchodilator Agents; Dos | 1996 |
Volume history response of airway resistance.
Topics: Adrenergic beta-Agonists; Airway Resistance; Albuterol; Asthma; Functional Residual Capacity; Humans | 1995 |
Pulmonary medicine.
Topics: Adrenergic beta-Agonists; Albuterol; Humans; Lung Diseases, Obstructive; Pulmonary Medicine; Respira | 1996 |
[Effect of 16-week use of salmeterol on ECP levels, pulmonary function tests and bronchial hyperreactivity in patients with chronic obstructive lung disease].
Topics: Albuterol; Blood Proteins; Bronchial Hyperreactivity; Bronchodilator Agents; Eosinophil Granule Prot | 1995 |
Salmeterol in smokers with COPD.
Topics: Albuterol; Bronchodilator Agents; Humans; Lung Diseases, Obstructive; Salmeterol Xinafoate; Smoking | 1996 |
Effect of salbutamol on oxygen saturation in COPD.
Topics: Administration, Inhalation; Aged; Albuterol; Bronchodilator Agents; Female; Humans; Lung Diseases, O | 1996 |
Exacerbation of psychosis associated with inhaled albuterol.
Topics: Administration, Inhalation; Adult; Albuterol; Bronchodilator Agents; Chronic Disease; Humans; Lung D | 1995 |
Dose-response to bronchodilator delivered by metered-dose inhaler in ventilator-supported patients.
Topics: Administration, Inhalation; Aerosols; Aged; Airway Resistance; Albuterol; Bronchodilator Agents; Dos | 1996 |
Probability of particle and salbutamol deposition in the respiratory tract: comparison between MDI and Autohaler.
Topics: Administration, Inhalation; Aerosols; Albuterol; Asthma; Bronchodilator Agents; Humans; Lung Disease | 1996 |
Who benefits from inhaled corticosteroids?
Topics: Administration, Inhalation; Administration, Topical; Adrenergic beta-Agonists; Albuterol; Anti-Infla | 1996 |
A week-long course of inhaled beta-agonist or anticholinergic agent may reduce dyspnea during exercise in COPD.
Topics: Administration, Inhalation; Adrenergic beta-Agonists; Albuterol; Cholinergic Antagonists; Dyspnea; H | 1996 |
Salmeterol for emphysema?
Topics: Adrenergic beta-Agonists; Albuterol; Humans; Lung Diseases, Obstructive; Pulmonary Emphysema; Salmet | 1996 |
A review and economic evaluation of bronchodilator delivery methods in hospitalized patients.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Albuterol; Bronchodilator Agents; Canada; Drug Costs; Fe | 1996 |
Evaluation of plasma and urinary salbutamol levels in COPD.
Topics: Administration, Inhalation; Aged; Albuterol; Analysis of Variance; Bronchodilator Agents; Female; Hu | 1996 |
Bronchodilator response in pulmonary disease at two different states of respiratory mechanics.
Topics: Adult; Airway Resistance; Albuterol; Asthma; Bronchodilator Agents; Cross-Sectional Studies; Female; | 1996 |
Optimal particle size for beta 2 agonist and anticholinergic aerosols in patients with severe airflow obstruction.
Topics: Adrenergic beta-Agonists; Aerosols; Airway Resistance; Albuterol; Bronchodilator Agents; Female; For | 1996 |
Respiratory resistive impedance in obstructive patients: linear regression analysis vs viscoelastic modelling.
Topics: Administration, Inhalation; Adrenergic beta-Agonists; Aged; Airway Resistance; Albuterol; Asthma; Br | 1997 |
Lung hyperinflation and flow limitation in chronic airway obstruction.
Topics: Adult; Albuterol; Asthma; Bronchoconstriction; Bronchodilator Agents; Case-Control Studies; Female; | 1997 |
Thermogenic effect of bronchodilators in COPD.
Topics: Albuterol; Bronchodilator Agents; Energy Metabolism; Humans; Lung Diseases, Obstructive | 1997 |
Long acting bronchodilators in chronic obstructive pulmonary disease.
Topics: Albuterol; Bronchodilator Agents; Drug Administration Schedule; Ethanolamines; Formoterol Fumarate; | 1997 |
[Effectiveness and tolerance of a combination of fluticasone and salmeterol in patients with obstructive airway diseases. DUO Study Group].
Topics: Administration, Inhalation; Adolescent; Adult; Aged; Albuterol; Androstadienes; Anti-Asthmatic Agent | 1998 |
Effect of regular use of high-dose nebulized beta2-agonists on resting energy expenditure, weight, and handgrip strength in patients with chronic airflow limitation.
Topics: Administration, Inhalation; Adrenergic beta-Agonists; Adult; Aged; Albuterol; Body Weight; Energy Me | 1998 |
Salbutamol inhalation has no effect on myocardial ischaemia, arrhythmias and heart-rate variability in patients with coronary artery disease plus asthma or chronic obstructive pulmonary disease.
Topics: Administration, Inhalation; Aged; Albuterol; Arrhythmias, Cardiac; Asthma; Blood Pressure; Bronchodi | 1998 |
Risk of emergency care, hospitalization, and ICU stays for acute asthma among recipients of salmeterol.
Topics: Adolescent; Adrenergic beta-Agonists; Adult; Age Factors; Albuterol; Anti-Asthmatic Agents; Asthma; | 1998 |
Acute effects of nebulized salbutamol on resting energy expenditure in patients with chronic obstructive pulmonary disease and in healthy subjects.
Topics: Adult; Aerosols; Age Factors; Aged; Airway Resistance; Albuterol; Body Composition; Bronchodilator A | 1998 |
[Evaluation of bronchial obstruction. Dyspnea, the quality of life].
Topics: Activities of Daily Living; Albuterol; Attitude to Health; Bronchi; Bronchodilator Agents; Dyspnea; | 1998 |
A comparison between clenbuterol, salbutamol and terbutaline in relation to receptor binding and in vitro relaxation of equine tracheal muscle.
Topics: Albuterol; Animals; Binding, Competitive; Bronchodilator Agents; Clenbuterol; Dose-Response Relation | 1998 |
Hemoptysis due to MDI therapy in a patient with permanent tracheostomy: treatment with mask AeroChamber.
Topics: Aged; Albuterol; Diagnosis, Differential; Granulation Tissue; Hemoptysis; Humans; Laryngectomy; Lung | 1999 |
Inhaled oxitropium bromide is currently used as the first-line therapy of patients with chronic pulmonary disease in Japan.
Topics: Administration, Inhalation; Adrenergic beta-Agonists; Aged; Albuterol; Bronchodilator Agents; Dose-R | 1999 |
Evidence of acinar airway involvement in asthma.
Topics: Adult; Aging; Albuterol; Asthma; Bronchodilator Agents; Female; Forced Expiratory Volume; Functional | 1999 |
Use of the combination product ipratropium and albuterol in chronic obstructive pulmonary disease.
Topics: Albuterol; Bronchodilator Agents; Drug Administration Schedule; Drug Combinations; Drug Therapy, Com | 1999 |
[Comparative effects of acute tests using ventolin, ventodisk and intal plus in the ambulatory pulmonological practice].
Topics: Albuterol; Ambulatory Care; Asthma; Bronchial Spasm; Bronchitis; Cromolyn Sodium; Humans; Lung Disea | 1999 |
Apples and oranges : flaws and guffaws.
Topics: Adrenergic beta-Agonists; Albuterol; Bronchodilator Agents; Cholinergic Antagonists; Dose-Response R | 1999 |
Sequentially induced sputum in patients with asthma or chronic obstructive pulmonary disease.
Topics: Administration, Inhalation; Administration, Oral; Adrenergic beta-Agonists; Adult; Aged; Albuterol; | 1999 |
Oral corticosteroid trials in the management of stable chronic obstructive pulmonary disease.
Topics: Administration, Oral; Adrenergic beta-Agonists; Albuterol; Analysis of Variance; Beclomethasone; Dru | 1999 |
Bronchodilators and mechanical ventilation in COPD patients. Emptying, pumping or both?
Topics: Albuterol; Bronchodilator Agents; Humans; Lung Diseases, Obstructive; Randomized Controlled Trials a | 1999 |
Lymphocytes apoptosis in patients with acute exacerbation of asthma.
Topics: Adult; Aged; Aged, 80 and over; Albuterol; Apoptosis; Asthma; Cells, Cultured; fas Receptor; Humans; | 1999 |
Use of the forced oscillation technique to assess airway obstruction and reversibility in children.
Topics: Administration, Inhalation; Adolescent; Airway Resistance; Albuterol; Bronchodilator Agents; Child; | 2000 |
The use of inhalers in patients with tracheal stomas or tracheostomy tubes.
Topics: Administration, Inhalation; Aged; Albuterol; Bronchodilator Agents; Drug Delivery Systems; Equipment | 1999 |
Factor analysis of changes in dyspnea and lung function parameters after bronchodilation in chronic obstructive pulmonary disease.
Topics: Albuterol; Bronchodilator Agents; Dyspnea; Factor Analysis, Statistical; Female; Humans; Lung Diseas | 2000 |
Seattle's breath of fresh air.
Topics: Administration, Inhalation; Albuterol; Asthma; Emergency Medical Services; Humans; Lung Diseases, Ob | 2000 |
Partial reversibility of airflow limitation and increased exhaled NO and sputum eosinophilia in chronic obstructive pulmonary disease.
Topics: Administration, Inhalation; Aged; Albuterol; Beclomethasone; Breath Tests; Bronchodilator Agents; Eo | 2000 |
The diagnosis and treatment of cough.
Topics: Acute Disease; Adrenergic beta-Agonists; Albuterol; Asthma; Bronchitis; Common Cold; Cough; Diagnost | 2001 |
Towards evidence based emergency medicine: best BETs from the Manchester Royal Infirmary. Salbutamol and ipratropium in COPD.
Topics: Albuterol; Drug Therapy, Combination; Emergency Medical Services; Evidence-Based Medicine; Humans; I | 2001 |
Lidocaine inhalation for cough suppression.
Topics: Administration, Inhalation; Adult; Aged; Albuterol; Anesthetics, Local; Antitussive Agents; Asthma; | 2001 |
Optimizing bronchodilator therapy for copd.
Topics: Albuterol; Bronchodilator Agents; Humans; Lung Diseases, Obstructive; Salmeterol Xinafoate; Theophyl | 2001 |
[What are the options other than smoking cessation? Public health illness COPD calls in experts for the plan].
Topics: Albuterol; Bronchodilator Agents; Clinical Trials as Topic; Humans; Lung Diseases, Obstructive; Salm | 2001 |
Does salmeterol increase mortality in patients with COPD?
Topics: Adrenergic beta-Agonists; Albuterol; Bronchodilator Agents; Humans; Lung Diseases, Obstructive; Salm | 2001 |
[Chronic bronchitis. Gold standard from the internet].
Topics: Adrenergic beta-Agonists; Albuterol; Androstadienes; Bronchitis; Bronchodilator Agents; Cholinergic | 2001 |
Glaucoma associated with metered-dose bronchodilator therapy.
Topics: Aged; Albuterol; Bronchodilator Agents; Case-Control Studies; Ethanolamines; Female; Formoterol Fuma | 2001 |
Use of forced inspiratory vital capacity to identify bronchodilator reversibility in obstructive lung disease.
Topics: Adult; Aged; Aged, 80 and over; Albuterol; Bronchodilator Agents; Female; Forced Expiratory Volume; | 2001 |
[Side-effects of beta-adrenergic drugs].
Topics: Adrenergic beta-Agonists; Albuterol; Angina Pectoris; Arrhythmias, Cardiac; Headache; Humans; Hypert | 1976 |
[Physiopathological and clinical studies on the use of beta-stimulating drugs].
Topics: Adrenergic beta-Agonists; Albuterol; Asthma; Drug Evaluation; Humans; Lung Diseases, Obstructive; Pu | 1976 |
[Therapy of bronchiolar obstruction with special reference to beta-adrenergic drugs].
Topics: Adrenal Cortex Hormones; Adrenergic beta-Agonists; Albuterol; Anti-Bacterial Agents; Cromolyn Sodium | 1976 |
Effect of respiratory drugs on mucociliary clearance.
Topics: Adrenergic beta-Agonists; Albuterol; Aminophylline; Animals; Beclomethasone; Cats; Chlorofluorocarbo | 1978 |
Autonomic control of pulmonary trapped gas volume in subhuman primates.
Topics: Albuterol; Animals; Atropine; Autonomic Nervous System; Bronchi; Disease Models, Animal; Functional | 1978 |
[Value and limitations of salbutamol in the treatment of the obstructive syndrome. Comparative study with a synthetic atropine-like agent].
Topics: Adult; Aged; Albuterol; Asthma; Atropine Derivatives; Bronchitis; Female; Humans; Ipratropium; Lung | 1976 |
[Treatment of spastic disorders of the bronchopulmonary tract with salbutamol tablets].
Topics: Administration, Oral; Albuterol; Bronchial Spasm; Female; Humans; Lung Diseases, Obstructive; Male; | 1979 |
Deposition and fate of aerosolized drugs.
Topics: Aerosols; Albuterol; Fenoterol; Forced Expiratory Volume; Histamine; Humans; Lung; Lung Diseases, Ob | 1978 |
Paranoid psychosis with Ventolin (salbutamol tablets b.p.)
Topics: Aged; Albuterol; Humans; Lung Diseases, Obstructive; Male; Paranoid Disorders; Psychoses, Substance- | 1978 |
[The effect of various beta 2-adrenergic bronchodilator agents in CARD patients].
Topics: Albuterol; Bronchodilator Agents; Fenoterol; Humans; Isoetharine; Lung Diseases, Obstructive; Terbut | 1977 |
[Salbutamol in the treatment of severe broncho-asthmatic attacks].
Topics: Adolescent; Adult; Aged; Albuterol; Asthma; Drug Evaluation; Female; Humans; Lung Diseases, Obstruct | 1977 |
[Effect of sympathomimetics (isoprenaline, alupent, salbutamol) on the level of free and esterified fatty acids in blood serum of patients with chronic pulmonary diseases].
Topics: Adult; Aged; Albuterol; Chronic Disease; Fatty Acids; Fatty Acids, Nonesterified; Female; Humans; Is | 1976 |
[Salbutamol therapy of chronic bronchopathic patients with cardiac arrhythmias].
Topics: Aged; Albuterol; Arrhythmias, Cardiac; Asthma; Chronic Disease; Female; Heart Rate; Humans; Lung Dis | 1976 |
[Study of the ventilatory and cardiocirculatory effects of a beta-2-stimulating drug (salbutamol) in patients with the respiratory dysfunctional syndrome of the obstructive type].
Topics: Adolescent; Adult; Aged; Albuterol; Asthma; Cardiovascular System; Drug Evaluation; Hemodynamics; Hu | 1976 |
[Changes in blood gases after inhalation of salbutamol in patients with chronic obstructive bronchopneumopathy].
Topics: Adult; Aged; Albuterol; Carbon Dioxide; Female; Humans; Lung Diseases, Obstructive; Male; Middle Age | 1976 |
[Respiratory function studies in patients with bronchopneumopathy treated with salbutamol].
Topics: Albuterol; Drug Evaluation; Humans; Lung Diseases, Obstructive; Metaproterenol; Respiration; Respira | 1976 |
[Clinical experience with delayed-action salbutamol].
Topics: Albuterol; Asthma; Chronic Disease; Delayed-Action Preparations; Drug Evaluation; Hemodynamics; Huma | 1976 |
[Study of the effects of salbutamol in chronic obstructive bronchopneumopathies].
Topics: Albuterol; Asthma; Drug Evaluation; Hemodynamics; Humans; Lung Diseases, Obstructive; Respiration; S | 1976 |
[Clinical and physiopathological study of obstructive bronchopneumopathies treated with salbutamol].
Topics: Albuterol; Drug Evaluation; Humans; Lung Diseases, Obstructive; Respiration; Respiratory Function Te | 1976 |
[Respiratory, cardiological and metabolic functional studies of the effects of salbutamol in bronchopathic patients of various ages].
Topics: Acid-Base Equilibrium; Adult; Albuterol; Blood Gas Analysis; Blood Glucose; Bronchial Spasm; Cardiov | 1976 |
[Comparison of the bronchodilator action of salbutamol and orciprenaline by aerosol administration in patients with chronic bronchopneumopathy].
Topics: Adult; Aerosols; Aged; Albuterol; Asthma; Bronchial Spasm; Bronchitis; Drug Evaluation; Female; Huma | 1976 |
[Bronchodilator action and side effects of salbutamol in patients with bronchospasm of the respiratory tract].
Topics: Adult; Aged; Albuterol; Asthma; Bronchitis; Bronchodilator Agents; Drug Evaluation; Dyspnea; Female; | 1976 |
[Salbutamol in the treatment of functional broncho-obstructive syndromes].
Topics: Adult; Aged; Albuterol; Cardiovascular System; Drug Evaluation; Female; Humans; Lung Diseases, Obstr | 1976 |
Stimulation of cyclic AMP production in human alveolar macrophages induced by inflammatory mediators and beta-sympathicomimetics.
Topics: Adenylyl Cyclases; Adrenergic beta-Agonists; Adult; Aged; Albuterol; Asthma; Cyclic AMP; Dinoproston | 1992 |
[A comparison of bronchodilating drugs in the treatment of stable COPD].
Topics: Administration, Inhalation; Administration, Oral; Albuterol; Bronchodilator Agents; Forced Expirator | 1992 |
Acute bronchodilator trials in chronic obstructive pulmonary disease.
Topics: Aerosols; Aged; Aging; Albuterol; Bronchodilator Agents; Drug Evaluation; Female; Forced Expiratory | 1992 |
A comparison of six different ways of expressing the bronchodilating response in asthma and COPD; reproducibility and dependence of prebronchodilator FEV1.
Topics: Adult; Aged; Albuterol; Asthma; Bronchi; Bronchodilator Agents; Cross-Sectional Studies; Female; For | 1992 |
The prehospital use of nebulized albuterol on patients with wheezing whose chief complaint is shortness of breath.
Topics: Adult; Aged; Albuterol; Asthma; Child; Child, Preschool; Emergency Medical Services; Female; Humans; | 1992 |
[Effect of salbutamol on heart rate in patients with atrial fibrillation].
Topics: Aged; Albuterol; Atrial Fibrillation; Female; Heart Rate; Humans; Lung Diseases, Obstructive; Male; | 1992 |
Simplifying the assessment of patients with chronic airflow limitation for home nebulizer therapy.
Topics: Adult; Aged; Aged, 80 and over; Albuterol; Drug Therapy, Combination; Female; Humans; Ipratropium; L | 1992 |
[Abolition of the salbutamol-induced bronchodilating effect during bronchial infection in patients with chronic obstructive bronchopulmonary diseases].
Topics: Albuterol; Chronic Disease; Humans; Lung Diseases, Obstructive; Middle Aged; Recurrence | 1992 |
[Lung function of adult patients with bronchial asthma or chronic obstructive lung disease prior to and following a 3-month-stay in the Dutch Asthma Center in Davos].
Topics: Albuterol; Asthma; Female; Hospitals, Special; Humans; Lung Diseases, Obstructive; Lung Volume Measu | 1992 |
The effects of inhaled albuterol and oral theophylline on gastroesophageal reflux in patients with gastroesophageal reflux disease and obstructive lung disease.
Topics: Administration, Inhalation; Administration, Oral; Adult; Aged; Albuterol; Delayed-Action Preparation | 1992 |
Respiratory symptoms as predictors of airways lability in an elderly population.
Topics: Aged; Aged, 80 and over; Albuterol; Bronchial Hyperreactivity; Female; Humans; Lung; Lung Diseases, | 1992 |
[The effect of inhaled salbutamol on pulmonary gas exchange in patients with chronic obstructive bronchopneumopathy].
Topics: Administration, Inhalation; Aged; Albuterol; Carbon Dioxide; Hemoglobins; Humans; Hypoxia; Lung Dise | 1992 |
Air-driven nebulised high-dose salbutamol in severe chronic obstructive airways disease: is it safe?
Topics: Aged; Albuterol; Delayed-Action Preparations; Drug Therapy, Combination; Female; Heart Rate; Humans; | 1991 |
A23187-induced pulmonary gas trapping and inflammation in the guinea pig.
Topics: Albuterol; Aminophylline; Animals; Atropine; Bronchial Spasm; Calcimycin; Granulocytes; Guinea Pigs; | 1991 |
Tolerance to beta 2-agonists in patients with chronic obstructive pulmonary disease.
Topics: Administration, Inhalation; Adrenergic beta-Agonists; Albuterol; Bronchodilator Agents; Dose-Respons | 1990 |
Increased bronchial hyperresponsiveness after inhaling salbutamol during 1 year is not caused by subsensitization to salbutamol.
Topics: Administration, Inhalation; Adrenergic beta-Antagonists; Albuterol; Asthma; Bronchi; Bronchial Provo | 1990 |
Bronchodilators in patients with chronic obstructive pulmonary disease on mechanical ventilation. Utilization of metered-dose inhalers.
Topics: Aged; Aged, 80 and over; Albuterol; Aminophylline; Bronchodilator Agents; Female; Hemodynamics; Huma | 1990 |
[Effect of nifedipine alone and in combination with salbutamol on the beat frequency of human nasal cilia].
Topics: Albuterol; Dose-Response Relationship, Drug; Drug Interactions; Humans; Lung Diseases, Obstructive; | 1990 |
Assessment of reversibility of airway obstruction in patients with chronic obstructive airways disease.
Topics: Airway Resistance; Albuterol; Humans; Lung Diseases, Obstructive; Prednisolone | 1990 |
Assessment of reversibility of airway obstruction in patients with chronic obstructive airways disease.
Topics: Albuterol; Female; Forced Expiratory Volume; Humans; Lung; Lung Diseases, Obstructive; Male; Middle | 1990 |
Improved cardiac performance by salbutamol, a selective beta 2-agonist, in chronic cor pulmonale.
Topics: Aged; Albuterol; Carbon Dioxide; Female; Hemodynamics; Humans; Infusions, Intravenous; Lung Diseases | 1987 |
How does salbutamol improve the ventricular performance in patients with chronic obstructive pulmonary disease?
Topics: Aged; Albuterol; Blood Pressure; Female; Heart; Humans; Lung Diseases, Obstructive; Male; Middle Age | 1988 |
The relationship between pulmonary function and dyspnea in obstructive lung disease.
Topics: Aged; Albuterol; Dyspnea; Female; Forced Expiratory Volume; Humans; Lung Diseases, Obstructive; Male | 1989 |
Impedance measurements of the respiratory system before and after salbutamol in COPD patients.
Topics: Airway Resistance; Albuterol; Female; Humans; Lung; Lung Diseases, Obstructive; Male; Middle Aged; O | 1989 |
Severe bronchospasm followed by respiratory arrest during thallium-dipyridamole imaging.
Topics: Aged; Albuterol; Bronchial Spasm; Dipyridamole; Humans; Lung Diseases, Obstructive; Lung Volume Meas | 1989 |
Early detection of lung function abnormalities in infants with cystic fibrosis.
Topics: Airway Resistance; Albuterol; Cystic Fibrosis; Humans; Infant; Infant, Newborn; Lung; Lung Diseases, | 1989 |
Salbutamol psychosis.
Topics: Administration, Inhalation; Albuterol; Dose-Response Relationship, Drug; Hallucinations; Humans; Lun | 1989 |
[Chronic obstructive lung diseases associated with systemic arterial hypertension].
Topics: Adrenergic beta-Agonists; Albuterol; Antihypertensive Agents; Chronic Disease; Drug Therapy, Combina | 1985 |
[Comparison of the effectiveness and tolerance of a new beta-2 stimulant (broxaterol) vs. salbutamol in patients with chronic obstructive bronchopneumopathy].
Topics: Adrenergic beta-Agonists; Adult; Aged; Albuterol; Female; Forced Expiratory Volume; Humans; Isoxazol | 1987 |
Protective effect of Duovent versus salbutamol in long-term treatment.
Topics: Airway Resistance; Albuterol; Atropine Derivatives; Drug Combinations; Drug Tolerance; Fenoterol; Fo | 1986 |
[Changes in blood potassium induced by the abuse of 3 beta 2-agonist drugs].
Topics: Administration, Inhalation; Aged; Albuterol; Clenbuterol; Ethanolamines; Female; Fenoterol; Humans; | 1987 |
Emergency use of nebulised bronchodilator drugs in British hospitals.
Topics: Aerosols; Albuterol; Asthma; Bronchodilator Agents; Drug Utilization; Emergencies; Hospitals, Distri | 1987 |
The assessment of a computer administered questionnaire in the differential diagnosis of asthma and chronic airflow limitation.
Topics: Adult; Aged; Albuterol; Asthma; Bronchi; Bronchial Provocation Tests; Diagnosis, Computer-Assisted; | 1988 |
Evidence of prednisolone induced mood change ('steroid euphoria') in patients with chronic obstructive airways disease.
Topics: Aged; Albuterol; Emotions; Euphoria; Forced Expiratory Volume; Humans; Lung Diseases, Obstructive; M | 1988 |
Measurement technique influences the response of transfer factor (TICO) to salbutamol in patients with airflow limitation.
Topics: Adult; Aged; Albuterol; Breath Tests; Carbon Monoxide; Female; Humans; Lung Diseases, Obstructive; M | 1988 |
Bronchodilators in chronic air-flow limitation. Effects on airway function, exercise capacity, and quality of life.
Topics: Aged; Albuterol; Bronchodilator Agents; Humans; Lung Diseases, Obstructive; Male; Middle Aged; Nebul | 1987 |
Effect of combined use of intravenous salbutamol and aminophylline on cardiac rhythm in chronic obstructive lung disease.
Topics: Aged; Albuterol; Aminophylline; Drug Therapy, Combination; Female; Heart Rate; Humans; Infusions, In | 1987 |
Variability and reversibility of the slow and forced vital capacity in chronic airflow obstruction.
Topics: Albuterol; Female; Humans; Lung; Lung Diseases, Obstructive; Male; Middle Aged; Vital Capacity | 1987 |
Post-mortem concentrations of salbutamol, terbutaline and theophylline in asthma patients.
Topics: Acute Disease; Adolescent; Adult; Aged; Aged, 80 and over; Albuterol; Animals; Asthma; Female; Human | 1987 |
Use of Haleraid in rheumatoid arthritis with obstructive lung disease.
Topics: Aerosols; Aged; Albuterol; Arthritis, Rheumatoid; Hand; Humans; Lung Diseases, Obstructive; Middle A | 1986 |
Comparative evaluation of lung functional changes with atropine methonitrate and salbutamol in plain and sustained forms.
Topics: Adult; Albuterol; Atropine Derivatives; Delayed-Action Preparations; Female; Humans; Lung Diseases, | 1986 |
Airway reactivity in chronic obstructive pulmonary disease. Failure of in vivo methacholine responsiveness to correlate with cholinergic, adrenergic, or nonadrenergic responses in vitro.
Topics: Aged; Albuterol; Bronchi; Bronchial Provocation Tests; Colforsin; Diterpenes; Female; Forced Expirat | 1985 |
Airway conductance (Gaw) and FEV 1 changes with aerosol bronchodilator and underlying mechanics.
Topics: Airway Resistance; Albuterol; Forced Expiratory Volume; Humans; Lung Diseases, Obstructive; Plethysm | 1986 |
Responses to large doses of salbutamol and theophylline in patients with chronic obstructive pulmonary disease.
Topics: Aged; Airway Resistance; Albuterol; Drug Therapy, Combination; Female; Forced Expiratory Volume; Hum | 1985 |
Acute carbon dioxide narcosis during inhalational therapy with oxygen powered nebulizers in patients with chronic airflow limitation.
Topics: Aerosols; Aged; Albuterol; Female; Humans; Hypercapnia; Lung Diseases, Obstructive; Male; Middle Age | 1985 |
[Pulmonary artery pressure in obstructive lung diseases before and after salbutamol administration].
Topics: Albuterol; Blood Pressure; Bronchitis; Cardiac Output; Heart Rate; Humans; Lung Diseases, Obstructiv | 1973 |
[Over-8-hour salbutamol effect in obstructive respiratory tract diseases].
Topics: Adult; Albuterol; Asthma; Bronchitis; Child; Chronic Disease; Humans; Lung Diseases, Obstructive; Ti | 1974 |